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ABSTRACT 
Stephani Page:  Analysis of Receiver Domain Dephosphorylation Kinetics 
(Under the direction of Robert Bourret) 
 
 Plants and microorganisms use two-component signal transduction systems (TCSs) to 
mediate responses to stimuli.  Canonical TCSs consist of a sensory component, the sensor kinase 
(SK), and a response-mediating component.  The phosphorylation state of the SK is regulated by 
the presence of stimuli.  The response-mediating component, the response regulator (RR) accepts 
the phosphoryl group from the SK.  Receiver domains are the conserved domain of RRs, and 
contain the site of phosphorylation, a conserved Asp.  Receiver domain dephosphorylation 
results in signal termination, and can occur through phosphotransfer to water or histidine.  The 
kinetics of self-catalyzed Asp ! water phosphotransfer (autodephosphorylation) of RRs appear 
to be tuned to the timescales of the biological processes in which RRs participate, and reported 
rate constants span six orders of magnitude. More complex variations of TCSs, called 
phosphorelays, contain histidine-containing phosphotransfer domain (Hpt), which contain the 
phosphoaccepting histidine in Asp ! His phosphotransfer.   
 First, we propose a strategy for assessment of functional variation within protein families.  
We used bioinformatics to guide experimental analysis of non-conserved receiver domain active 
site residues D+2 and T+2 (two amino acids C-terminal to conserved Asp phosphorylation site 
and Thr/Ser, respectively).  Using bioinformatics, we were able to determine a representative and 
feasible set of D+2/T+2 pairs to assess for kinetic effects on receiver domain
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autodephosphorylation.  We also report results of additional bioinformatics analysis of receiver 
domain sequences assigned to RR subfamilies (determined by the presence of specific output 
domains).!
 Second, this work represents the first reported demonstration of a small molecule analog 
for Hpts in TCSs.  Imidazole is the functional group of His.  Here, we characterize the imidazole-
mediated dephosphoryation reaction of receiver domains.  Additionally, we use imidazole to 
probe non-conserved active site residues as potential determinants of TCS Asp ! His 
phosphotransfer reactions.  Further, we show the structure of a receiver domain in the presence 
of a phosphomimic and imidazole. 
This work presents novel approaches to answering fundamental questions regarding 
receiver domain dephosphorylation reactions in two-component systems, and proposes avenues 
to further probe phosphotransfer reactions in TCSs and functional variation in protein families in 
general. 
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CHAPTER 1: INTRODUCTION 
1.1 BACKGROUND 
1.1.1 Microbial signal transduction.  The ability of organisms to respond to 
environmental changes is a necessity.  For microorganisms, environmental changes are sensed 
through the detection of stimuli such as light, chemical compounds, or temperature (1-5).  Signal 
transduction encompasses the processes that detect stimuli, internally represent the presence of 
stimuli, and elicit appropriate responses.  Signal transduction systems in microorganisms 
regulate processes that range from cell division and development to virulence and motility.  
Motivations of studies of microbial signal transduction include understanding of fundamental 
molecular strategies for signaling, revealing potential targets and agents for prevention and 
treatment of disease (6-9), and improving and developing industrial applications (10-16).   
1.1.2 Protein phosphorylation in signal transduction.  Although the possible stimuli 
and responses encompass a great deal of variety, there are very few categories of molecular 
processes that are employed as a means to encode the presence of stimuli (5, 17).  One 
fundamental molecular strategy for signal transduction is protein phosphorylation (17-19).  
Despite the essentiality of phosphotransfer reactions in biological processes, even beyond signal 
transduction, questions remain regarding fundamental aspects of phosphotransfer reactions, such 
as whether enzymes change the transition states of catalyzed reactions compared to the 
uncatalyzed reactions, how enzymes stabilize transition states, whether phosphotransfer proceeds 
through stepwise versus concerted reactions, and contributions from the nucleophile and/or 
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leaving groups (18, 20). 
1.1.3 Two-component signal transduction.  Plants, yeast, bacteria, and archaea use two-
component signal transduction systems (TCSs) to mediate responses to stimuli (1, 17, 21).  Any 
one bacterium can contain upward of a hundred individual TCSs.  Canonical TCSs contain a 
sensory and a response-mediating component (Fig. 1.1), and employ phosphotransfer to encode 
the presence of stimuli.  The phosphorylation state of the sensory component, the sensor kinase 
(SK), is regulated by the presence of stimuli.  The SK contains a variable input domain that 
detects stimuli.  The SK self-catalyzes the phosphorylation of its own conserved histidine with 
the γ-phosphoryl group of ATP.  The phosphoryl group is then transferred from the SK to a 
conserved aspartate on the response-mediating component, called a response regulator (RR).  
The RR may contain a variable output domain that mediates the appropriate response.  The RR 
then transfers the phosphoryl group to water through self-catalyzed or phosphatase-aided 
dephosphorylation, producing inorganic phosphate (Pi).  RR dephosphorylation results in signal 
termination.  
1.1.4 Response regulator architecture.  Response regulators can be single domain 
proteins or contain variable output domains (17, 22, 23).  Classification of response regulators is 
typically based on the structure of the output domain, if one is present (24).  Broad categories of 
output domains inform the types of molecular processes that response regulators are involved in: 
protein-binding domains, DNA-binding domains, enzymatic domains, etc. (24, 25).  For 
response regulators that are single domains, molecular function may involve direct binding to an 
effector protein, such as in the case of Escherichia coli chemotaxis response regulator CheY (25-
27). 
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1.2 RECEIVER DOMAINS  
1.2.1 Receiver domains of response regulators.  Receiver domains are the conserved 
domains of RRs (22, 23).  Receiver domains contain the conserved aspartate that is the site of 
phosphorylation in addition to four conserved residues that mediate phosphorylation chemistry:  
two consecutive aspartates (denoted DD) that coordinate the required divalent metal, a conserved 
threonine (or serine) and lysine that directly coordinate the phosphoryl group (denoted T and K, 
respectively) (Fig. 1.2).  Nomenclature of non-conserved residues in receiver domains is based 
on proximity to conserved residues.  For example, non-conserved residues located two positions 
C-terminal to the conserved Thr/Ser are named “T+2”.  Receiver domains also have a conserved 
structure consisting of alternating β-strands and α-helices.  In the folded protein, the five β-
strands are arranged in a β-sheet sandwiched by the five α-helices.  The phosphorylation active 
site is contained within the loops that connect the strands and helices. 
1.2.2 Variation in proteins containing receiver domains.  Increased complexity in 
TCSs results in greater regulation of the flow of phosphoryl groups and, therefore, response-
mediation.  There are variations of TCSs (28) in which receiver domains are contained in 
proteins other than response regulators (29).  Phosphorelays, for example, are variations of TCSs 
that typically contain two receiver domains; one as a part of a canonical response regulator, and 
another as a part of a hybrid kinase (30-33).  In hybrid kinases, the phosphoryl group is 
transferred from a SK domain to a C-terminal receiver domain within the same protein.  Within 
phosphorelays, dephosphorylation of the hybrid kinase receiver domain is the source of signal 
termination. 
1.2.3 Receiver domain phosphotransfer reactions.  As briefly discussed before, 
receiver domains contain a conserved aspartate as the site of phosphorylation.  Receiver domains 
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self-catalyze their own phosphorylation with small molecular phosphodonors (34), and contain 
the core catalytic machinery of His ! Asp phosphotransfer.  One small molecule phosphodonor, 
acetyl phosphate is physiologically available (35).  In canonical two-component systems the flow 
of phosphoryl groups around the receiver domain include phosphotransfer from the SK histidine 
to the receiver domain aspartate, then from the receiver domain aspartate to water resulting in the 
following reaction scheme: ATP ! SK ! RR ! water or ATP ! His ! Asp ! water (Fig. 
1.3).  Recall that phosphorelays can (but do not always) use hybrid kinases that contain a 
receiver domain in addition to a canonical response regulator.  Phosphorelays also vary from 
canonical TCSs by using a histidine-containing phosphotransfer domain (Hpt) – which is the 
phosphotransfer domain that connects the two receiver domains (30, 31).  In phosphorelays, the 
phosphotransfer reaction scheme is: ATP ! His1 ! Asp1 ! His2 ! Asp2! His2 ! Asp1 ! 
water (Fig. 1.3), where His1 and His2 are in the SK and Hpt domains, respectively.  Notably, the 
presence of the Hpts in phosphorelays adds in Asp ! His phosphotransfer, which is not a feature 
of canonical TCSs.  Additionally, while Asp ! water phosphotransfer is non-reversible (Pi 
product) essentially removing phosphoryl groups from the system, Asp ! His phosphotransfer is 
reversible, potentially adding another layer of regulation (17, 21). 
1.2.4 Receiver domain dephosphorylation biochemistry.  Phosphorylated receiver 
domains contain phosphate monoesters.  Loss of phosphoryl groups by self-catalyzed 
dephosphorylation, or autodephosphorylation, occurs through nucleophilic attack on the 
phosphoryl group by water.  The water must attack directly in-line with the P-O bond of the 
aspartyl phosphate (23, 36-38).  The proposed transition state consists of a planar PO32- 
coordinated by the conserved threonine, lysine, and the divalent metal ion (36) (Fig. 1.2). In 
phosphatase-aided dephosphorylation, the receiver domain still catalyzes the reaction, and 
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residues from the phosphatase serve to enhance the reaction through mechanisms such as 
positioning of the nucleophile (39-44).  In addition to water, histidines (from Hpts) act as 
nucleophiles for attack on phosphorylated receiver domains in TCSs (17, 45).   
Similar to water, direct in-line attack is also required when a histidine is acting as the 
nucleophile, but it was previously unclear what differences and similarities existed between 
water- and histidine-mediated dephosphorylation of response regulators.  Though structural 
analysis suggests that the receiver domain contains the primary catalytic machinery of Asp ! 
His phosphotransfer (46), we were not aware of experimental demonstration of catalysis of the 
reaction by a receiver domain prior to our work reported here.  We found that both reactions 
require the intact receiver domain active site, and that receiver domains contain the primary 
catalytic machinery of Asp ! His phosphotransfer.  In order for the imidazole to attack the 
phosphoryl group, the imidazole must be deprotonated, resulting in a pH-dependence not 
observed with reactions with water.  Imidazole-mediated dephosphorylation is at least 1000-fold 
faster than water-mediated dephosphorylation, depending on the D+2/T+2 residues present. 
Further, water- and imidazole-mediated dephosphorylation are both influenced by D+2/T+2 
residues, but the reactions may be influenced differently, such that residues at D+2/T+2 may 
discriminate between the two nucleophiles. 
1.2.5 Receiver domain evolution.  Despite the conserved features of receiver domains, 
response regulators have evolved to interact with various protein domains including SKs, Hpts, 
RR output domains, and phosphatases (17, 47, 48).  Interestingly, some phosphorelays evolved 
such that degenerate SKs lost ATPase activity and function solely as Hpts (49), while some Hpts 
have altogether different origins and structures (45).  Hpts could represent one avenue of co-
evolution of receiver domains.  Receiver domains have been shown, however, to co-evolve with 
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SKs and output domains (4, 32, 50).  Analyses also showed that SK and output domains can 
influence what residues are found at specific positions within receiver domains (4, 50). 
1.3 OVERVIEW OF DISSERTATION WORK 
1.3.1 Chapter 2.  Using bioinformatics-guided assessment of non-conserved features 
to probe functional variation within protein.  In the age of high-throughput genome 
sequencing, the number of protein sequences attributed to protein families is rapidly growing.  
DNA sequences are translated into protein sequences, which are aligned to identify areas of 
sequence similarity.  Areas of protein sequence similarity define conserved domains, which are 
then used to identify members of specific protein families.   
Two decades ago, sequence analysis of RRs involved fewer than one hundred protein 
sequences (22).  Now, the MiST2 database contains ~250,000 receiver domains sequences (1).  
The availability of such a large number of sequences begs the question of how to utilize 
sequence information beyond assigning sequences to broad protein families.  Bioinformatics 
analysis, in general, involves the use of computational tools to probe, for example, databases of 
sequence information for patterns or relationships.   
As stated previously, RR dephosphorylation results in signal termination in canonical 
TCSs.  Reported rate constants for the self-catalyzed dephosphorylation of wild type RRs span a 
nearly one million-fold range, and appear to be tuned to the relevant biological timescales of the 
processes being regulated (51-53).  In considering potential determinants of the variation in RR 
autodephosphorylation rate constants, sequence and structural analyses revealed that residues at 
D+2 and/or T+2 (two positions C-terminal to the site of phosphorylation Asp and conserved 
Thr/Ser, respectively) are positioned appropriately to influence chemistry (52).  Based on mutual 
information analysis of residues within receiver domains, D+2/T+2 score strongly for co-
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variation (54) – ranking #6 out of ~6000 pairwise comparisons - and appear to have co-evolved 
(unpublished, Thane Miller and Robert Bourret).   
The following text is a summary of work and observations detailed in Chapter 2. 
Bioinformatics analysis of a non-redundant database of receiver domain sequences 
revealed that 5% of possible D+2/T+2 pairs represented 50% of receiver domain sequences.  
Furthermore, analysis of D+2/T+2 distribution across different RR subfamilies (determined by 
output domains) showed an enrichment of particular D+2/T+2 pairs within individual RR 
subfamilies in a manner that suggests functional importance.   
Using two receiver domains – E. coli CheY and PhoB - residues at D+2 and T+2 were 
changed, and assessed for kinetic effects on autodephosphorylation, expanding previous analysis 
using CheY and Bacillus subtillus Spo0F.  Previous work by Thomas, et al. (52) and Pazy, et al. 
(36, 52) involving analysis of 17 E. coli CheY variants and nine B. subtilis Spo0F variants 
focused on mimicking active sites of fewer than ten wild type response regulators.  This work 
expands analysis by adding 26 new CheY variants and analysis in E. coli PhoB.   
Residues at D+2 and T+2 modulated RR autodephosphorylation rate constants over two 
orders of magnitude.  All but one D+2/T+2 pair tested in two different receiver domains had 
similar effects on autodephosphorylation.  Further, autodephosphorylation rate constants for 
CheY variants correlated to audodephosphorylation rate constants of wild type RRs containing 
the same D+2/T+2 pair.   
Negative charge at D+2 and/or T+2 may be a key enhancing feature in the influence 
receiver domain autodephosphorylation.  One potential mechanism of influence is through direct 
interaction with the nucleophile. 
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1.3.2 Chapter 3.  Characterization of a new small molecule analog for TCSs.  
Receiver domains can transfer phosphoryl groups to water or histidine.  The functional side 
chain of histidine is the imidazole ring.  Despite the knowledge that small molecule 
phosphodonors for receiver domains had been informative in dissecting determinants of His ! 
Asp phosphotransfer (34), we are not aware of any previous demonstration that a small molecule 
other than water could accept phosphoryl groups from receiver domains.   
The following text is a summary of work and observations detailed in Chapter 3.   
Imidazole acts as a nucleophile and accepts the phosphoryl group from receiver domains, 
forming monophosphoimidazole (MPI).  Additionally, imidazole reacts with RR-P similarly to 
an Hpt; reversible phosphotransfer was achieved with a receiver domain, and imidazole reacted 
in place of an Hpt in an artificial phosphorelay.  The structure of activated CheY in complex with 
imidazole showed that residues at D+2, T+1 and T+2 directly contacted the imidazole, and that 
the imidazole is oriented similarly to the histidine from an Hpt.  We assessed CheY variants that 
either mimicked phosphorelay receiver domains or contained characteristically different amino 
acids at D+2, T+2, and/or T+1.  Kinetic analysis of CheY variants showed that residues at D+2 
and T+2 influence the reaction with imidazole.  Additionally, residues at D+2 and T+2 appeared 
to distinguish between water and imidazole as nucleophiles, which was more pronounced in 
CheY variants that mimicked phosphorelay RRs, suggesting that D+2/T+2 residues influence 
recognition of nucleophiles.   
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1.4 FIGURES 
 
Figure 1.1  Canonical two-component signal transduction components. 
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Figure 1.2  Active site of receiver domain CheY.  Structure of E. coli receiver domain CheY in 
which the conserved active site residues are shown in purple (Panel A).  The phosphomimic and 
required divalent metal are colored yellow and green, respectively.  The transition state model 
(Panel B) shows the coordination of the phosphoryl group by the conserved Thr and Lys, along 
with the divalent metal – which is coordination by the two conserved aspartates, called DD.   
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Figure 1.3  Phosphotransfer schemes of two-component signal transduction systems.  Canonical 
TCSs are represented in panel A, and phosphorelays are represented in panel B.  Phosphorelays 
use an additional receiver domain and a histidine-containing phosphotransferases (Hpt).  
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CHAPTER 2:  BIOINFORMATICS GUIDED ANALYSIS OF FUNCTIONAL 
VARIATION IN PROTEIN FAMILIES: RECEIVER DOMAIN 
AUTODEPHOSPHORYLATION1 
2.1 SUMMARY 
Plants and microorganisms use two-component signal transduction systems (TCSs) to 
mediate responses to environmental stimuli.  TCSs mediate responses through phosphotransfer 
from a conserved histidine on a sensor kinase to a conserved aspartate on the receiver domain of 
a response regulator.  Typically, signal termination occurs through dephosphorylation of the 
receiver domain, which can catalyze its own dephosphorylation.  Despite strong structural 
conservation between receiver domains, reported autodephosphorylation rate constants (kdephos) 
span a million-fold range.  Non-conserved receiver domain active site residues D+2 and T+2 
(two amino acids C-terminal to conserved phosphorylation site and Thr/Ser respectively) 
influence kdephos values, but the extent and mechanism of influence are unclear.  We used 
bioinformatics analysis of a large database of naturally occurring receiver domain sequences to 
design mutant receiver domains for deeper kinetic analysis of autodephosphorylation.  When 
combined with previous analyses, kdephos values were obtained for CheY variants that represented 
D+2/T+2 pairs found in 55% of receiver domain sequences.  kdephos of CheY variants altered at 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!1!This work was submitted for publication in the Journal of Bacteriology. Bioinformatics 
analysis methods, software, and databases were developed by Robert Immormino, Thane Miller, 
and Robert Bourret.  All experimental analyses were completed by Stephani Page.  Stephani 
Page wrote the manuscript for publication with the assistance of Robert Bourret, Thane Miller, 
Robert Immormino, and Ruth Silversmith. 
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D+2/T+2 correlated with kdephos of wild type receiver domains containing the same D+2/T+2 pair.  
Further, a given pair of amino acids!at D+2/T+2 generally had similar effects on kdephos in CheY,
PhoBN, and Spo0F.  Negative charge at D+2/T+2 enhanced kdephos.  Rate constants for 
autophosphorylation with phosphoramidate and autodephosphorylation of CheY variants altered 
at D+2/T+2 were inversely correlated, suggesting D+2/T+2 residues interact with aspects of the 
ground or transition states that differ between the two reactions.  Additionally, particular 
D+2/T+2 pairs are enriched in different response regulator subfamilies, suggesting functional 
significance. 
In the age of genomics, one protein family can include hundreds of thousands of 
sequences.  Characterization of a conserved domain can lead to prediction of general function.  
However, a general strategy to assess features that differentiate between members of the same 
protein family (e.g. non-conserved residues in a conserved domain) would be useful.  Fully 
exploring just two positions could mean assessment of 400 (20 x 20) variants.  Instead, we 
created and analyzed a non-redundant database of receiver domain sequences.  Five percent of 
D+2/T+2 pairs in the database were sufficient to represent 50% of receiver domain sequences.  
Using bioinformatics to prioritize mutant choice made it feasible to experimentally probe the 
influence of positions D+2 and T+2 on receiver domain autodephosphorylation. 
2.2 INTRODUCTION 
Two-component systems (TCSs) are a prevalent means of signal transduction used by 
plants and microorganisms to mediate responses to stimuli (21).  Present in over 95% of 
! 14 
sequenced bacterial genomes (4, 29), one species contains tens to more than a hundred TCSs.  
TCSs regulate a wide range of processes from cell development to virulence.  Signal 
transduction by TCSs occurs through the transfer of phosphoryl groups between histidyl and 
aspartyl residues of different protein components (17).  Canonically, the sensory component (the 
sensor kinase) is a phosphodonor to the response regulator (the response-mediating component) 
(17).  The conserved domain in the response regulator, the receiver domain, functions as a 
molecular switch.  The phosphorylation status of a conserved Asp on the receiver domain 
corresponds to turning the output response on and off.  Typically, receiver domain 
phosphorylation initiates the output response, and dephosphorylation terminates the response.  
Dephosphorylation can occur with the assistance of another protein, such as a phosphatase, or by 
self-catalysis by the receiver domain, which is termed autodephosphorylation.  
Reported autodephosphorylation rate constants of receiver domains span almost six 
orders of magnitude (51) (Fig. 2.1).  The large variation in receiver domain 
autodephosphorylation kinetics is striking in light of the strong conservation of structure amongst 
receiver domains.  There are now almost 300 structures of receiver domains in the RCSB Protein 
Data Bank (55, 56).  Receiver domains have a conserved Rossmanoid fold structure, with a beta 
sheet made up of five beta strands, surrounded by five alpha helices (23).  Five conserved 
residues and a divalent metal ion are arranged in a conserved geometry and comprise the active 
site that catalyzes both the phosphorylation and dephosphorylation of the conserved Asp (23).  
Despite the conserved fold and active site geometry, on average any two receiver domains will 
have only about 25% amino acid sequence identity (22) – suggesting that there is a fair amount 
of variability from one receiver domain to the next. 
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Non-conserved residues located within or close to the receiver domain active site could 
potentially be positioned to exert influence on the catalysis of autodephosphorylation. Residues 
at D+2 (located two amino acids C-terminal to the site of phosphorylation on the β3-α3 loop) and 
T+2 (located two amino acids C-terminal to the conserved Thr/Ser on the β4-α4 loop) are located 
such that their side chains may potentially interact with conserved active site residues, the 
phosphoryl group, and/or the attacking water nucleophile.  In previous studies using a limited set 
of Escherichia coli CheY and Bacillus subtilis Spo0F mutants based on the wild type sequences 
of fewer than ten receiver domains, we found that the particular amino acids at positions D+2 
and T+2 altered the autodephosphorylation rate constant by almost two orders of magnitude (36, 
52).  Due to the small data set, the full extent to which residues at D+2 and T+2 can influence 
receiver domain autodephosphorylation is unknown.  Further, the mechanisms by which 
positions D+2 and D+2 influence autodephosphorylation remain unclear. 
Here, we extend investigation of the D+2 and T+2 residues and their influence on 
receiver domain autophosphorylation by significantly expanding our data set to be much more 
representative of response regulators.  Pursuing a larger and more relevant data set would 
potentially mean that conclusions could be applied more broadly to receiver domains.  However, 
expansion of the data set would need to be experimentally feasible.  Bioinformatics analysis 
revealed that 20 (out of 400 possible) D+2/T+2 pairs account for 50% of receiver domain 
sequences found in a non-redundant database of naturally occurring response regulators – in 
essence, only 5% of possible amino acid pairs accounts for the majority of amino acid sequences.  
We also expanded our experimental analysis to include another receiver domain, PhoBN, 
representative of a large family of response regulators.  Combined with previous studies, the 43 
D+2/T+2 pairs tested in CheY represent 55% of receiver domain sequences.  Analysis of the 
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expanded mutant collection showed that residues at D+2 and T+2 modulated 
autodephosphorylation rate constants over two orders of magnitude, indicating that additional 
factors are required to account for the much larger range of kdephos values reported for response 
regulators.  A particular pair of amino acids at D+2 and T+2 generally had similar effects on 
autodephosphorylation in different response regulators.  Negatively charged amino acids at D+2 
or T+2 enhanced autodephosphorylation in all three receiver domains tested, but positively 
charged amino acids did not have a consistent effect on hydrolysis.  The previously measured 
rate constants for autophosphorylation with phosphoramidate (57) and autodephosphorylation of 
CheY variants that differ at D+2 and T+2 are inversely correlated, suggesting the amino acids at 
D+2 and T+2 interact with aspects of the ground or transition states that differ between the two 
reactions.  
Finally, analysis of receiver domains from different response regulator families revealed 
dramatically different distributions of D+2/T+2 pairs between receiver domain subclasses.  
Typically, a few pairs composed of chemically similar amino acids and exerting similar effects 
on the autodephosphorylation rate constant dominated the D+2/T+2 pairs in each response 
regulator family.  The biased distribution strengthens the notion that amino acids at positions 
D+2 and T+2 are functionally important. 
2.3 MATERIALS AND METHODS 
2.3.1 Bioinformatics analysis.  To analyze the frequency of amino acids that naturally 
occur at various positions within receiver domains, we created a searchable database of non-
redundant receiver domain amino acid sequences using a combination of publicly available web-
based utilities and databases along with custom Perl (v5.16) scripts.  The choice of D+2/T+2 
combinations for experimental work was guided by preliminary analyses made several years ago 
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(data not shown).  The up-to-date analysis used to generate amino acid frequencies given in this 
report is described below.   
The sequences of 250,546 proteins containing receiver domains, identified using the 
Agfam signaling domain library of the Microbial Signal Transduction (MiST2.2) database (1), 
were provided by the curators on February 11, 2015 (Database S2).  To reduce bias and 
redundancy from multiple closely related genomes, one genome (the first encountered in the list) 
was chosen for each genus and proteins from all other genomes in the same genus were 
discarded.  This process left 39,132 sequences.  Random reordering of the original list of 
sequences using a Fisher-Yates shuffle resulted in different genome sequences being in the final 
database, but did not significantly change reported results.  
To facilitate sequence alignment, protein sequences were trimmed to retain only the 
receiver domain(s).  First, a unique AseqID (58) was assigned to each protein sequence database 
entry.  The AseqIDs were then used to query the Agfam annotation in SeqDepot (58) to retrieve 
the location of the first and last residues of each receiver domain.  Amino acids outside of the 
receiver domain(s) were discarded.  Because some proteins contain more than one receiver 
domain, the number of database entries increased to 41,370.  USEARCH v5.1.221 (59) was used 
to group the receiver domain sequences into clumps of 1,000 (a manageable size for alignment) 
based on sequence similarity.  The sequences in each clump were then aligned using MUSCLE 
v3.8.31 (60).  To further reduce the redundancy of the database, sequences within each clump 
were compared in a pairwise manner.  Sequences with ≥ 90% identity to the amino acids (gap 
positions were not tested) of a query sequence were discarded.  This step removed 2,989 
sequences (7.2% of the total) and did not significantly affect the amino acid frequencies at 
position D+2 and T+2 in the final database.  Because the clumps were created based on sequence 
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similarity and response regulators are on average only ~25% identical (22), the screen against 
high sequence identity was not applied between clumps. 
The positions of the five conserved active site residues that are critical for receiver 
domain function (23) were then located.  Each clump of aligned sequences was searched to 
identify the positions that had the highest number of matches to "DD" (two adjacent Asp and/or 
Glu residues), "D" (Asp only), "T" (Ser or Thr), and "K" (Lys only) with the constraint that the 
identified positions must occur in the listed order from N- to C-terminal.  The 6,772 sequences 
that did not initially appear to contain all five conserved residues were cycled through the 
clumping, alignment, and conserved residue identification procedures again.  On the second 
filtering attempt, 1,643 sequences met the criterion of containing all five conserved residues.  
Most of the sequences that passed upon rescreening came from the same few clumps in the first 
attempt and appeared to have initially failed due to sequence misalignment.  Sequences that 
passed the first and second attempts were pooled to yield a collection of 33,252 receiver domain 
sequences.  The 5129 sequences (13.4%) that failed to pass the second screen for the presence of 
all five conserved residues were presumed to be pseudo-receiver domains (61) and were not 
considered further. 
Receiver domains share a three dimensional structure of alternating β-strands and α-
helices, with the conserved residues on the loops at the C-terminal ends of β-strands 1, 3, 4, and 
5 (23).  The nine loops connecting the five β-strands and five α-helices often differ in length 
between different receiver domains.  Therefore, a header indicating the position of the DD, D, T, 
and K landmarks was added to each receiver domain sequence and gaps introduced during 
multiple sequence alignment were removed.  This left a primary receiver domain database 
(Database S3) in which the amino acid at a given position with respect to a landmark (e.g. D+2, 
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where + signifies in the C-terminal direction and - signifies in the N-terminal direction) can be 
identified for each entry in spite of differences in length.  Sequences that match a specified 
search criterion (e.g. Met at position D+2) can also be retrieved. 
Finally, response regulators can be categorized based on their output domains (24).  
Therefore, the primary receiver domain database was subdivided into secondary databases 
representing the major classes of response regulators.  The AseqID was used to query Seqdepot 
for the Pfam (62) domain annotation associated with each protein in the primary database.  The 
presence of specific domains led to assignment to families as follows: PF00486 (Trans_reg_C) 
domain, OmpR family; PF00196 (GerE) domain, NarL/FixJ family; both PF00158 
(Sigma54_activat) and PF02954 (HTH_8) domains, NtrC family; PF04397 (LytTr) domain, 
LytR family; PF02518 (HATPase_c) domain, hybrid kinase family.  Proteins that had exactly 
one receiver domain in Agfam annotation and no domains other than PF00072 (Response_reg) in 
Pfam were assigned to the single receiver domain family.  188 proteins (~0.6%) were assigned to 
more than one family.  6697 proteins were not assigned.  The sorting process resulted in seven 
secondary databases (the six families listed above plus the proteins without assignment) that can 
be individually searched (Databases S4-S10).  Databases created for this work are available at 
http://www.unc.edu/~bourret/PageSupplementalDatabaseFiles.htm.  
2.3.2 Mutagenesis and protein purification.  Plasmids encoding His6-tagged CheY 
variants were made using QuikChange (Agilent) with the plasmid pKC1 (63) as the template.  
CheA was purified as described (52).  Each CheY variant was purified as described (51) and 
removal of the His6-tag by thrombin cleavage left three additional residues (GSH) on the N-
terminus. The additional GSH does not affect CheY autodephosphorylation kinetics (51).  
Plasmids encoding His6-tagged PhoB1-127 variants used pET28a-phoBN (63), which encodes a 
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thrombin cleavable His6-tagged PhoB1-127, as a template.  Thrombin cleavage leaves the N-
terminal GSH.  PhoB variants were purified as described for CheY.  His6-tagged PhoR193-431 was 
expressed and purified as described (63).  All protein variants were gel filtered using a Superdex 
75 1660 size exclusion column (GE Biosciences) to remove impurities. 
We apply a nomenclature for discussion of CheY and PhoBN mutants in which the first 
letter is the D+2 residue and the second letter is the T+2 residue.  One D+2/T+2 pair in the top 
20 was not assessed.  EL (D+2 is E, T+2 is L), twelfth in abundance, was made in CheY, but 
attempts at protein purification were unsuccessful.  Only six of the next 14 pairs were tested.  
The GY, KF, KH, RS, EY, HD, TY, and HS pairs (#21-23, 28-31, 33, respectively) were not 
made because they were not among the most prevalent pairs in our initial database analysis.  
Notably, analysis of Spo0F in (52) included three pairs (EL, KH, and EY) missing from the 
CheY mutant set. 
2.3.3 Autodephosphorylation rate constant measurement using 32P. 
Autodephosphorylation rate constants for CheY variants were measured by following the loss of 
32P as described (51).  CheY variants (8 µM) were incubated with 0.5 µM purified [32P]CheA-P 
(64) in 100 mM Tris at pH 7.5 and 10 mM MgCl2.  Because some substitutions resulted in 
diminished rates of phosphotransfer from [32P]CheA-P to CheY, incubations times were varied 
for different CheY mutants in order to ensure that at least 95% of the 32P was transferred by the 
first time point.  At each time point, 6 µL of the reaction was removed and mixed with an equal 
volume of 2X SDS sample buffer to quench the reaction. Components of samples taken at each 
time point were separated using SDS-PAGE.  Loss of 32P from [32P]CheY-P was detected using 
phosphorimaging analysis of the dried gel.  The signals were quantified using pixel volume 
analysis in which the background signal was manually subtracted. The amounts of [32P]CheY-P 
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were plotted versus time and fit to one phase exponential decays yielding the 
autodephosphorylation rate constant, kdephos.  Each time course was designed to follow loss of 32P 
over at least 4-5 half lives (~3-6% 32P remaining on [32P]CheY-P).  All measurements were 
repeated three times.   
To determine the autodephosphorylation rate constants of PhoBN variants, 4 µM His6-
tagged PhoR was incubated with 0.3 mM [γ-32P]ATP in 3.5 mM MgCl2, 35 mM KCl, and 35 
mM Tris pH 8.0 for 30 minutes at room temperature to generate [32P]PhoR-P.  The reaction 
mixture containing [32P]PhoR-P was pipetted onto a 0.22 µm PVDF centrifugal filter column 
(Millipore) containing ~200 mL of a Ni-NTA Agarose (Qiagen) slurry that was equilibrated in 
35 mM Tris pH 8.0, 3.5 mM MgCl2, and 35 mM KCl buffer.  After centrifugation, the column 
was washed multiple times with equilibration buffer to remove excess ATP.  PhoBN (wild type 
PhoB1-127) (90 µM in 60 µL of equilibration buffer) was added directly to the slurry, mixed, and 
then incubated at room temperature for 5 min on the column to allow for sufficient 
phosphotransfer from [32P]PhoR-P to PhoBN.  The column was centrifuged to elute [32P]PhoBN-P.  
Time courses were completed and phosphorimaging was analyzed as described above for CheY. 
2.4 RESULTS 
2.4.1 20 D+2/T+2 pairs account for half of receiver domain sequences.  Previous 
analysis of the influence of D+2 and T+2 residue pairs on receiver domain 
autodephosphorylation (52) was limited to pairs that mimicked fewer than ten receiver domains.  
Bioinformatics was employed to guide experimental design for assessing the impact of D+2/T+2 
residues in a manner that represented receiver domains more broadly and that was 
experimentally feasible.  After accessing receiver domain sequences from the MiST2 database 
(1), a non-redundant database of 33,252 receiver domain sequences was created by reducing 
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sequences to one genome per genus and then removing sequences with ≥ 90% sequence identity 
(Database S3).  Out of 400 possible amino acid combinations at D+2 and T+2, 364 pairs were 
present (Fig. 2.2).  Strikingly, 20 D+2/T+2 pairs (only 5% of the possible combinations) 
accounted for 50% of natural receiver domain sequences.  The pair frequencies are displayed in 
Figure 1 such that the bubble area reflects the total number of sequences in our database that 
contain a specific D+2/T+2 pair (Fig. 2.3).  Some pairs, such as MK (the first letter is the D+2 
residue and the second letter is the T+2 residue) and MR, were quite abundant, each accounting 
for more than 5% of sequences analyzed.  CheY mutants were made with the goal of completing 
a set of the most common D+2/T+2 pairs.  In the end, the collection included 19 of the top 20 
and 25 of the 34 most frequent D+2/T+2 pairs (wild type CheY pair NE was #11).  Because 
making the majority of D+2/T+2 pairs in CheY required double substitutions, single mutants 
were also made and tested in order to determine the contribution of each D+2 or T+2 substitution 
individually.   
2.4.2 Substitutions at D+2 and T+2 in CheY modulated autodephosphorylation rate 
constants over two orders of magnitude.  Autodephosphorylation rate constants were 
measured for 26 CheY variants.  With consolidated CheY data from (36, 52), the expanded data 
set (Table 2.1) contained twelve D+2 single mutants, ten T+2 single mutants, and 20 double 
mutants in CheY that, together (including the NE pair found in wild type CheY), represent 55% 
of receiver domains.  At T+2, amino acids L, K, R, H, and Y were assessed in (52), and 
expanded to include Q, S, A, N, and F in this study.  All T+2 single substitutions removed the 
wild type Glu in CheY and resulted in diminished autodephosphorylation rate constants (Table 
2.1).  Overall, single substitutions at T+2 modulated rates constants over a 10-fold range, similar 
to what was reported in (52).  Rate constants for T+2 single mutants appeared to decrease as 
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residue size and hydrophobicity increased; aromatics (H, Y, F) made up the slowest T+2 single 
mutants.   
In contrast, single substitutions at D+2 (changing the Asn) resulted in both enhanced and 
diminished rate constants.  D, M, E, K, and L were assessed at D+2 in (52), which was extended 
to include S, Q, V, A, R, G, and W in this study.  Overall, single substitutions at D+2 resulted in 
a ~30-fold range in rate constants.  Almost all (11/12) D+2 single mutants resulted in rates 
constants that were within three-fold of wild type CheY.  One D+2 single mutant (Trp), which 
slowed the reaction by 11-fold, was responsible for the added order of magnitude in the range of 
CheY D+2 single mutants.   
Double mutants DL, EH, MR, MK, and KY were analyzed in (52); RH and ML were 
analyzed in (36).  This study expanded analysis of CheY double mutants to include: ER, QN, SH, 
QH, GR, AA, QF, QY, VK, WH, RF, RY, and VY.  A ~30-fold range in autodephosphorylation 
rate constants was observed for the consolidated CheY double mutants with simultaneous 
substitutions at D+2 and T+2.  All of the CheY D+2/T+2 double mutants exhibited diminished 
autodephosphorylation rate constants compared to wild type.  Altogether, single and double 
substitutions at D+2 and T+2 in CheY resulted in a range in autodephosphorylation rate 
constants that spans two orders of magnitude.   
The previously studied data set included 16 CheY variants (accounting for 23% of 
receiver domain sequences) and resulted in a ~90-fold range in autodephosphorylation rate 
constants (52). Given the small sample size, it was unknown whether the previously observed 
range of rate constants represented an upper bound or a lower bound for the effect of D+2 and 
T+2 residues on autodephosphorylation.  Increasing the data set to 43 CheY variants (55% of 
receiver domain sequences) only expanded the range of CheY autodephosphorylation rate 
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constants by ~30% to 120-fold.  The expanded data set is more representative of naturally 
occurring D+2/T+2 pairs than the original, and includes D+2/T+2 pairs found in wild type 
response regulators exhibiting a five order of magnitude range in autodephosphorylation rate 
constants.  Therefore, we can reasonably expect to attribute about two orders of magnitude of the 
range in wild type response regulator autodephosphorylation rate constants to the particular 
amino acids at positions D+2 and T+2 and conclude that other factors must contribute to 
variation between receiver domains in the rate of autodephosphorylation.   
2.4.3 Substitution mimicking CheY at T+2 in PhoBN enhanced 
autodephosphorylation.  E. coli PhoBN, a receiver domain with a relatively slow 
autodephosphorylation rate constant (63), was used to analyze substitutions that could potentially 
enhance autodephosphorylation.  This expands a previous approach using the B. subtilis Spo0F 
response regulator (52).  PhoB was chosen for multiple reasons.  Whereas CheY and Spo0F are 
single domain response regulators, PhoB has an output domain and is representative of the large 
OmpR class of response regulators.  Although the presence or absence of the output domain has 
little effect on PhoB autodephosphorylation (63), receiver and output domains within response 
regulators have co-evolved (32, 50), and D+2/T+2 residues conceivably could have different 
effects in PhoBN than in a single domain response regulator.  Another contrast with CheY and 
Spo0F is that PhoBN forms dimers (65).  To the best of our knowledge, PhoBN is the only 
response regulator for which autodephosphorylation rate constants have been measured in 
different multimeric states.  The autodephosphorylation rate constants for monomeric PhoBN-P, 
the PhoBN•PhoBN-P heterodimer, and the PhoBN-P•PhoBN-P homodimer are indistinguishable 
(63), removing a potential complication from interpretation of data.   
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Single and double substitutions at D+2 and T+2 were made in PhoBN (changing Met and 
Arg at D+2 and T+2, respectively) that mimic CheY (Table 2.2).  Mutants with Glu substitutions 
at T+2 resulted in the largest increases compared to the wild type PhoBN autodephosphorylation 
rate constant (PhoBN NE and PhoBN ME autodephosphorylated 18- and 45-fold faster than wild 
type PhoBN, respectively). 
The PhoBN mimics of CheY were compared to single and double Ala mutants of PhoBN. 
Steric occlusion, i.e. hindrance of the in-line attack of nucleophilic water by large residues, was 
previously hypothesized as one mechanism by which D+2 and T+2 residues might influence 
receiver domain autodephosphorylation (36).  Based on this hypothesis, removal of the large Arg 
and/or Met residues by substitution to Ala should result in enhanced autodephosphorylation.  The 
autodephosphorylation rate constant of PhoBN AR was unchanged from wild type PhoBN, 
whereas rate constants for PhoBN MA and PhoBN AA were both two-fold faster than wild type 
PhoBN.  The relatively small effect of single and double Ala substitutions in PhoBN suggests that 
steric obstruction is not the key mechanism of influence by D+2/T+2 residues.  Because 
introducing a Glu at T+2 had a much larger effect than an Ala, it is clear that the key influence in 
the enhanced autodephosphorylation rate constant of PhoBN ME was from adding a beneficial 
feature of Glu as opposed to removing a detrimental feature of Arg.   
2.4.4 Autodephosphorylation rate constants appear to be influenced by negative 
charge.  The magnitude of effects between the same D+2/T+2 pairs in CheY and PhoBN were 
similar (Fig. 2.4).  Generally, similar effects of D+2/T+2 pairs were also previously observed 
between CheY and Spo0F (52) (Fig. 2.4).  The observation that the effects were similar 
regardless of backbone suggests that there may be some generality to the effect of a particular 
D+2/T+2 pair.  Kinetic data was analyzed to probe for mechanistic insight that could be applied 
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to all three backbones, thus indicating generality.  Data was analyzed to determine whether 
kinetic effects correlated to features of the amino acids (such as size, solvent accessibility, 
hydrophobic surface area) present at D+2 and T+2.  Though relationships were not observed for 
other features, a plot of autodephosphorylation rates constants against net charge at D+2 and T+2 
revealed that more negatively charged active sites correlated to faster autodephosphorylation rate 
constants (best fit R2 = 0.44) (Fig. 2.5).  Deeper inspection provides additional evidence that 
charge had a role in modulating autodephosphorylation.  There are 13 CheY variants with Glu at 
T+2 (Table 2.1).  Because the D+2 residue was varied experimentally, for purposes of discussion, 
this class of variants is designated XE.  Of the XE variants, 12 have a related double mutant in 
which the Glu is replaced with another amino acid, designated XZ.  In all 30 of the CheY XE 
versus XZ comparisons, the autodephosphorylation rate constant is faster for the XE variant (Fig. 
2.6A).  Because Glu is the wild type residue at T+2 in CheY, the result could be explained as 
loss of wild type function.  However, in both PhoBN (3/3) and Spo0F (6/6) (Fig. 2.6A) - in which 
Glu is not the wild type residue at T+2 - all of the XE mutants tested resulted in a gain of 
function compared to the corresponding XZ mutants.  The dominant accelerating effect of Glu at 
T+2 in CheY is consistent with the modest range in autodephosphorylation rate constants for 
CheY XE mutants (with the exception of CheY WE). 
Acidic residues at D+2 similarly correlated to faster autodephosphorylation rate constants.  
The CheY variants with an acidic residue at D+2 are designated EX, where E represents either 
acidic residue.  There are 34 comparisons between EX pairs in CheY and variants that have the 
D+2 residue replaced, designated ZX (Fig. 2.6B).  Out of the 33 comparisons, there were 30 in 
which the EX variant was faster than the ZX variant.  Two of the four exceptions contain the 
wild type CheY D+2 residue Asn.  In two comparisons, Glu is replaced with an Asp or Met.  
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Spo0F, acidic substitutions at D+2 resulted in faster autodephosphorylation (52).  There are two 
Spo0F EX variants that can be compared to ZX variants with the same T+2 residue.  Of the four 
Spo0F comparisons, all of the EX variants autodephosphorylated faster (Fig. 2.6B).  There were 
no PhoBN mutants in this study that contain an acidic residue at D+2. 
Deeper inspection of positively charged residues did not yield similar outcomes.  When 
looking amongst groupings of variants that included some with a positively charged residue (Arg, 
Lys, or His), we did not discern a relationship between kinetic data and removal or addition of a 
positive charge.  Further, because His has a pKa within a reasonable pH range for 
autodephosphorylation experiments, we were able to directly assess pH-dependence of CheY 
variants with a His at T+2.  Changing the pH will alter the charge of a His between neutral and 
positive.  Autodephosphorylation rate constants of the CheY QH, RH, and WH variants were not 
affected by pH (data not shown), suggesting that positive charge at T+2 may not influence 
autodephosphorylation. Alternatively, positively charged residues (K, R, H) also contain large 
hydrophobic surface areas.  Thus, hydrophobic surface area or size, rather than positive charge, 
may be the means by which Arg, Lys, and His residues influence autodephosphorylation.   
2.4.5 CheY autophosphorylation with PAM and autodephosphorylation vary 
inversely.  In addition to autodephosphorylation, receiver domains self-catalyze phosphorylation 
with small molecule phosphodonors, such as phosphoramidate (PAM), monophosphoimidazole 
(MPI), and acetyl phosphate (AcP).  Analysis in CheY showed that residues at D+2 and T+2 
influence autophosphorylation with small molecule phosphodonors (57).  We analyzed kinetic 
data for CheY autodephosphorylation versus CheY autophosphorylation rate constants with 
PAM, MPI, and AcP reported in (57), and observed a correlation with autophosphorylation with 
PAM.  There were 20 CheY variants for which both autodephosphorylation and PAM 
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autophosphorylation rate constants were measured.  Plotting kdephos versus kphos/Ks revealed an 
inverse relationship between the rate constants for the two reactions (Fig. 2.7).   
 The plot of kdephos versus kphos/KS showed informative correlations between the amino 
acids found at T+2 and the rate constants for each reaction.  Pairs containing residues with 
hydrophobic surface areas and/or that are large typically had faster PAM autophosphorylation 
rate constants and slower autodephosphorylation rate constants (Fig. 2.7).  Pairs containing acid 
or amide residues at T+2 were typically faster for autodephosphorylation and slower for PAM 
autophosphorylation, with CheY variants containing an acid residue at T+2 having the greatest 
impact. In contrast to enhancing autodephosphorylation in CheY, more negative active sites 
diminished autophosphorylation with PAM (57), consistent with the inverse relationship between 
kdephos and kphos/KS.   
2.4.6 Certain D+2/T+2 pairs are enriched in receiver domains from different classes 
of response regulators.  D+2/T+2 pairs with at least one negatively charged residue only make 
up three out of the top 20 pairs (Fig. 2.3).  Because response regulator families with different 
output domains have different functions, we wanted to determine whether particular D+2/T+2 
pairs were associated with specific response regulator families, and, potentially, with specific 
response regulator function.  The primary non-redundant database of receiver domain sequences 
(Database S3) was divided into seven secondary databases (Databases S4 – S10) based on 
association with major classes of response regulators as described in ‘Materials and Methods’.  
Subfamilies (Table 2.3) represented the following fractions of the non-redundant database: 
Hybrid kinases – 24%, OmpR – 20%, single receiver domains – 18%, NarL/FixJ – 12%, NtrC – 
6%, LytR – 4%.  16% of sequences were not assigned to a response regulator family in our 
analysis.  We analyzed the smaller databases to determine whether D+2/T+2 pairs were 
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distributed differently.  Strikingly, while MK and MR made up 14% of receiver domain 
sequences overall, they made up 49% of receiver domain sequences in the OmpR family (Table 
2.3).  Further, 72% of all sequences containing MK or MR are in the OmpR family.  OmpR 
family receiver domains typically function to regulate transcription, a relatively slow process, 
and receiver domains containing MK or MR at D+2/T+2 have autodephosphorylation rate 
constants at the slow end of the range of wild type response regulators.  Changing D+2/T+2 in 
CheY to MK or MR made CheY autodephosphorylation rate constants at least an order of 
magnitude slower (Table 2.1).  
Similar relationships were observed in other response regulator families (Table 2.3). For 
example, the distribution of the most common D+2/T+2 pairs containing a negative charge is 
informative. Prevalent in chemotaxis, CheYs consist of a single receiver domain and typically 
contain an NE pair.  While NE represents less than 2% of receiver domain sequences overall, the 
pair makes up 8% of single receiver domain sequences.  78% of sequences overall that contained 
an NE pair are found in the ‘single receiver domain’ database.  Whereas ER is found in 1.1% of 
receiver domain sequence, this D+2/T+2 pair represents 3.4% of receiver domains in hybrid 
kinases.  75% of receiver domains that contain an ER pair are found in the ‘hybrid kinase’ 
database.   CheB-type response regulators contain a methylesterase domain (24) and are not part 
of the other response regulator families chosen for analysis in Table 2.3.  CheB receiver domains 
typically contain the EL D+2/T+2 pair.  The ‘non-assigned’ database contained 78% of the EL-
representative receiver domain sequences overall.  It is striking that the NE, EL, and ER 
combinations of amino acids at D+2 and T+2 are strongly enriched in response regulators that 
require rapid autodephosphorylation for function.  Signal transduction in chemotaxis occurs in a 
fraction of a second (66) and the receiver domain in hybrid kinases often functions as a 
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phosphate sink to drain phosphoryl groups out of the system through autodephosphorylation (67-
70). The enrichment of particular D+2/T+2 pairs in receiver domains within different response 
regulator families strengthens the correlation between which D+2/T+2 pairs are present in a 
receiver domain and the biological function of that particular receiver domain.   
2.5 DISCUSSION 
2.5.1 Autodephosphorylation rate constants of CheY variants correlate to wild type 
response regulators with the same D+2/T+2 pair.  Observed autodephosphorylation rate 
constants for CheY, Spo0F, PhoBN variants were generally consistent with the effects of 
substitutions at D+2 and T+2 anticipated from rate constants for wild type response regulators 
containing the same D+2/T+2 pairs.  For example, wild type Rhodobacter sphaeroides PrrA is at 
the slower end of the range of autodephosphorylation rate constants for wild type response 
regulators, and contains RY at D+2/T+2.  In CheY, the RY variant is one of the slowest of the 
CheY variants (Table 2.1). The correlation between kdephos for wild type response regulators and 
corresponding CheY variants generally holds in spite of the observation that the effects of 
changing amino acids at D+2 and T+2 in CheY are sufficient to account for <1% of the range in 
autodephosphorylation rate constants observed among wild type response regulators.  When log 
kdephos for wild type response regulators was plotted versus log kdephos for CheY variants with the 
same D+2/T+2 pair, there was a direct correlation (R2 = 0.7) (Fig. 2.8). Presumably, the 
correlation indicates that other factors affecting kdephos often evolved to reinforce the direction set 
by the amino acids at D+2 and T+2. 
2.5.2 Residues at D+2 and T+2 modulated CheY autodephosphorylation over a 
continuous range.  Further, consistent with autodephosphorylation rate constants of wild type 
response regulators spanning a continuous range, the rate constants for 43 CheY mutants 
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(including variants containing Ala) are spread continuously over a range of values rather than 
grouped into functional versus non-functional classes (Table 2.1 and Fig. 2.1).  The continuous 
rather than bimodal distibution suggests that residues at D+2 and T+2 are influential but not 
essential for receiver domain autodephosphorylation.  
2.5.3 Mechanistic insights from inverse relationship between CheY kdephos and 
kphos/KS.  Analysis of relationships between autodephosphorylation rate constants and amino 
acid characteristics revealed that negative charge at D+2/T+2 influenced the 
autodephosphorylation reaction (Fig. 2.6).  Because the correlation between negative charge at 
D+2/T+2 and enhanced kdephos was consistent in three different receiver domains, there was the 
potential for further analysis to reveal generally applicable mechanistic insights.  Comparison of 
rate constants for autodephosphorylation and autophosphorylation with PAM for 20 CheY 
variants (Fig. 2.7) elucidated potential explanations for the negative charge correlation.   
 Receiver domains self-catalyze both dephosphorylation and autophosphorylation with 
small molecule phosphodonors, such as PAM.  Both reactions are substitution reactions at the 
phosphoryl atom.  The proposed transition states for autodephosphorylation and 
autophosphorylation are similar, including a planar PO32- and a partially formed Asp-P bond (36, 
57).  If residues at D+2 and T+2 affected aspects of the transition states that are similar, it would 
be reasonable to expect a direct correlation between the two reactions.  However, the observed 
inverse correlation indicated that residues at D+2 and T+2 affected features of the two transition 
states that are not similar. Obvious differences between the reactions include the ground states 
(CheY-P for autodephosphorylation versus CheY for autophosphorylation), and the regions of 
the transition states near the water (nucleophile for autodephosphorylation) or PAM 
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(phosphodonor for autophosphorylation).  Notably, the residues at D+2/T+2 are within 
appropriate distance to affect the regions around the water or PAM.   
 In contrast to enhancing autodephosphorylation, negative charge at D+2/T+2 correlates to 
diminished CheY autophosphorylation with PAM (57).  Thomas, et al. proposed that the 
diminishing effects were due to charge repulsion between the incoming PAM anion and the 
negative charge on the side chains.  For autodephosphorylation, interactions between the 
incoming water and the negatively charged side chains could enhance the reaction by stabilizing 
the attacking water molecule.  Alternatively, increased negative charge in the vicinity of the 
phosphoryl group could destabilize the ground state. 
2.5.4 Amino acids enriched in response regulator subfamilies correlate to 
autodephosphorylation kinetics.  In some of the response regulator subfamilies represented in 
this work, particular amino acids were enriched at D+2 and/or T+2.  For example, in the ‘LytR’ 
subfamily, 82% of residues found at T+2 are aromatic (Y, F, H) (data not shown).  Similarly, in 
the ‘NtrC’ subfamily, 81% of sequences contain an aromatic amino acid as the T+2 residue (data 
not shown).  However, there are distinctions in what residues are prevalent at D+2 in the two 
subfamilies.  For ‘LytR’ 52% of sequences contain a Gln or Glu at D+2 as opposed to Arg and 
Lys, which are found at D+2 in 53% of ‘NtrC’ sequences.  In this case, it appears that the residue 
at D+2 may distinguish between functional timescales and mechanisms for influence. 
Not surprisingly, D+2/T+2 combinations of the most prevalent residues represent a large 
fraction of sequences in each subfamily database:  QY, EY, QF, EF, QH, and EH make up 44% 
of ‘LytR’ sequences; RY, KY, RF, KF, RH, and KH make up 50% of ‘NtrC’ sequences.  CheY 
variants containing prevalent pairs from ‘LytR’ and NtrC’ subfamilies grouped together based on 
kinetic results (Table 2.1).  CheY variants containing QY, QF, QH, or EH have similar 
! 33 
autodephosphorylation rate constants.  Likewise, the kdephos values of CheY variants containing 
RY, RF, RH, or KY grouped together.  It is reasonable to expect that, given the correlations 
between association with a particular subfamily and the effect on CheY autodephosphorylation, 
one could roughly predict the autodephosphorylation rate constants for CheY variants containing 
EF, EY, KF, or KH (closely related variants not yet tested).  Using similar relationships may 
enhance our ability to estimate kinetic effects on autodephosphorylation as a result of containing 
a certain D+2/T+2 pair. 
2.5.5 Bioinformatics-guided experimental design has broad implications in strategies 
to assess variation within protein families.  With the advancements in genome sequencing, the 
known sizes of protein families have dramatically increased.  While conserved domains identify 
the family to which a protein belongs, questions of functionality remain.  Assessment of 
functionality within a protein family has historically focused on conserved residues within the 
conserved domain.  Typically, amino acid sequences are aligned to determine the conserved 
residues, the conserved residues are changed to alanines or other amino acids, and the mutant 
proteins are assessed using functional assays.  However, when considering the different 
functionalities within a family of proteins, it is often the non-conserved features that distinguish 
one protein in a family from another.  Bioinformatics analysis dramatically enhanced the 
feasibility of studying non-conserved features of a large protein family, response regulators.  Not 
only were we able to assess receiver domain autodephosphorylation kinetics of a mutant set that 
reflects what is found in nature, but we were also able to gain more confidence in the 
mechanistic insights elucidated by an expanded data set.  Whereas previous work on 17 CheY 
variants indicated steric occlusion as a key means of influence by D+2/T+2 pairs on 
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autodephosphorylation, the larger data set reported here suggests with more confidence that 
negative charge is a key means of influence.   
Bioinformatics analysis also revealed distinctions between response regulator subfamilies.  
The D+2/T+2 pairs enriched in the response regulator subfamily databases (Table 2.3) 
modulated autodephosphorylation in ways that are consistent with the biological functions 
associated with those response regulators.  The ability to further analyze protein sequences by 
grouping them into subcategories (such as the response regulator families used here) combined 
with the knowledge of influence from non-conserved features (such as results from changing 
D+2/T+2 reported here) could provide further mechanistic insight into functional variation with 
protein families.  
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2.6 TABLES 
 
 
Table 2.1 CheY autodephosphorylation rate constants 
    Fold change 
Amino acid at  from 
 D+2 T+2 kdephos (min-1) wild type   
wild type 
  N E 2.2 ± 0.2 NA  
T+2 single mutants 
   N Q 2.1 ± 0.07 -1.0  
  N L 1.6 ± 0.1a -1.4  
 N  S 1.2 ± 0.04 -1.8  
  N A 1.2 ± 0.1 -1.9  
  N K 1.2 ± 0.3a -1.8  
 N N 0.88 ± 0.04 -2.5  
 N R 0.69 ± 0.04a -3.2  
 N H 0.55 ± 0.04a -4.1  
 N Y 0.26 ± 0.01a -8.5  
  N F 0.20 ± 0.04 -11  
D+2 single mutants 
  D E 5.5 ± 0.4a +2.5  
  M E 4.6 ± 0.5a +2.1  
 E E 3.4 ± 0.3 +1.5  
  S E 3.3 ± 0.2 +1.5  
 Q E 3.2 ± 0.4 +1.4  
  K E 3.0 ± 0.1a +1.4  
  V E 2.2 ± 0.2 -1.0  
 A E 1.8 ± 0.2 -1.2  
 R E 1.6 ± 0.04 -1.4  
 L E 1.3 ± 0.1a -1.7  
  G E 1.0 ± 0.1 -2.2  
  W E 0.20 ± 0.02 -11  
Double mutants  
  E R 1.3 ± 0.1 -1.7  
 Q N 0.91 ± 0.04 -2.4  
  D L 0.57 ± 0.08a -3.9  
 E H 0.50 ± 0.03a -4.4  
  S H 0.39 ± 0.05 -5.6  
 Q H 0.30 ± 0.03 -7.2  
 G R 0.30 ± 0.04 -7.2  
  A A 0.30 ± 0.02 -7.3  
  Q F 0.28 ± 0.04 -7.8  
 Q Y 0.22 ± 0.02 -9.9  
 V K 0.10 ± 0.006 -21  
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 W H 0.098 ± 0.01 -22  
 M R 0.094 ± 0.012a -23  
 M K 0.078 ± 0.004a -28  
 K Y 0.062 ± 0.006a -35  
  R H 0.060 ± 0.008b -37  
  M L 0.060 ± 0.006b -37  
 R F 0.056 ± 0.003 -39  
 R Y 0.048 ± 0.004 -46  
  V Y 0.045 ± 0.008 -49  
aAutodephosphorylation rate constants from (52) 
bAutodephosphorylation rate constants from (36) 
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Table 2.2 PhoBN autodephosphorylation rate constants 
     Fold change 
Amino acid at  from 
 D+2 T+2 kdephos (min-1) wild type  
wild type  
  M R 0.015 ± 0.002 NA 
T+2 single mutants  
  M E 0.67 ± 0.06 +45 
  M A 0.024 ± 0.003 +1.6 
D+2 single mutants  
  N R 0.024 ± 0.003 +1.6 
  A R 0.018 ± 0.003 +1.2 
Double mutants  
  N E 0.27 ± 0.03 +18 
  A A 0.024 ± 0.004 +1.6 
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2.7 FIGURES 
!
Figure 2.1 Ranges for kdephos.  Data for ‘wild type response regulator’ and ‘Spo0F’ from (40, 52, 
53, 71-73). Data for CheY and PhoB are from Tables 2.1 and 2.2, respectively.  ‘n’ equals the 
number of variants measured in each receiver domain.  Rate constants for wild type CheY, 
Spo0F, and PhoB are denoted by gray circles, diamonds, and triangles, respectively. 
  
!! 40 
!
!
Figure 2.2 Bubble plot showing distribution of D+2/T+2 pairs found in a non-redundant receiver 
domain database (Database S3).  The position of the bubble corresponds to a certain D+2 (x-
axis)/T+2 (y-axis) pair.  The area of the bubble reflects the frequency of that pair in the database. 
In purple are the 5% of pairs that make up 50% of sequences.   ! !
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!
Figure 2.3 Top 50 D+2/T+2 pairs in non-redundant database of 33,252 receiver domain 
sequences.  Pairs in blue were tested in CheY, Spo0F, and/or PhoB.!! !
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!
 
Figure 2.4 Normalized autodephosphorylation rate constants for same D+2/T+2 pairs in 
different receiver domains.  Rate constants for variants containing a specific D+2/T+2 pair are 
normalized using the NE variant for each receiver domain.  Variants are identified by single 
letter amino acid abbreviations, where the first letter is the D+2 residue and the second letter is 
the T+2 residue.  Dark blue is CheY variants (wild type NE).  Orange is Spo0F variants (wild 
type KY).  Cyan is PhoBN variants (wild type MR). Y-axis scales are different between each data 
set. ! !
N
or
m
al
ize
d+
ra
te
+c
on
st
an
ts
+
CheY+vs+Spo0F* CheY+vs+PhoB*
NR+NE+ AA+ME+KY+ MR+NH+NE+ NY+NL+ KE+
0"
0.5"
1"
1.5"
2"
2.5"
3"
0"
0.2"
0.4"
0.6"
0.8"
1"
1.2"
1.4"
1.6"
!! 43 
 
Figure 2.5  Correlation between net charge at positions D+2 and T+2 and CheY 
autodephosphorylation rate constants.  His was considered neutral for calculations of net charge.  
Best fit R2 = 0.44.  ! !
!! 44 
 
Figure 2.6  Comparisons of effects on kdephos due to removal of acidic residue at T+2 (XE in 
Panel A) and D+2 (EX in Panel B) in CheY, Spo0F, and PhoBN.  
! !
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Figure 2.7  Relationship between CheY kdephos  and kphos/KS with PAM.  kphos/KS rate constants 
from (57).  Wild type CheY is indicated in red. 
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Figure 2.8  Correlation between kdephos for wild type response regulators (52) (and Fig. 2.1 
legend) and CheY variants (Table 2.1) with same residues at positions D+2 and T+2.  Best fit R2 
= 0.69. 
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CHAPTER 3:  IMIDAZOLE AS A SMALL MOLECULE ANALOG IN TWO-
COMPONENT SIGNAL TRANSDUCTION23 
3.1 SUMMARY 
In two-component signal transduction systems (TCSs), responses to stimuli are mediated 
through phosphotransfer between protein components.  Canonical TCSs use His ! Asp 
phosphotransfer in which phosphoryl groups are transferred from a conserved His on a sensory 
histidine kinase (HK) to a conserved Asp on a response regulator (RR).  RRs contain the 
catalytic core of His ! Asp phosphotransfer, evidenced by the ability of RRs to 
autophosphorylate with small molecule analogs of phospho-His proteins.  Phosphorelays are a 
more complex variation of TCSs that additionally utilize Asp ! His phosphotransfer through the 
use of an additional component, the histidine-containing phosphotransferase (Hpt), which reacts 
with RRs both as phosphodonors and phosphoacceptors.  Here we show that imidazole has 
features of a rudimentary Hpt.  Imidazole acted as a nucleophile and attacked phosphorylated 
RRs (RR-P) to produce monophosphoimidazole (MPI) and unphosphorylated RR.  
Phosphotransfer from RR-P to imidazole required the intact RR active site, indicating that the 
RR provided the core catalytic machinery for Asp ! His phosphotransfer.  Imidazole functioned 
in an artificial phosphorelay to transfer phosphoryl groups between unrelated RRs.  The X-ray !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!2!This work was reprinted with permission from Biochemistry,!54!(49),!pp!7248–7260. 
Copyright 2015 American Chemical Society. 3!Protein crystals were prepared by Ruth Silversmith. X-ray crystallographic data collection, 
structure solution and refinement were completed by Edward Collins.  All other experimental 
analyses were completed by Stephani Page.  Stephani Page wrote the manuscript with the 
assistance of Robert Bourret, Ruth Silversmith, and Edward Collins. 
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crystal structure of an activated RR•imidazole complex showed imidazole oriented in the RR 
active site similarly to the His of an Hpt.  Imidazole interacted with RR non-conserved active site 
residues, which influenced the relative reactivity of RR-P with imidazole versus water.  Rate 
constants for reaction of imidazole or MPI with chimeric RRs suggested that the RR active site 
contributes to the kinetic preferences exhibited by the YPD1 Hpt. 
3.2 INTRODUCTION 
Microorganisms across all domains of life as well as slime molds and plants use two-
component systems (TCSs) to mediate responses to stimuli (21, 74).  TCSs regulate many 
different biological functions from development and motility (21) to antibiotic resistance (75, 76) 
and virulence (77, 78).  In TCSs, the “signal” is transmitted amongst protein components through 
the transfer of phosphoryl groups.  The initial phosphotransfer event occurs when the sensory 
component, the stimulus-regulated histidine kinase (HK), catalyzes phosphotransfer from ATP to 
its own conserved His.  Phosphotransfer proceeds to a conserved Asp on the receiver domain of 
the response-mediation component, the response regulator (RR).  Phosphorylation activates the 
RR to carry out its output function, e.g. transcription regulation.  Finally, termination of the 
signal results from phosphotransfer from the RR Asp to water.  Thus, the typical pathway for 
phosphotransfer in a canonical TCS is ATP ! His ! Asp ! H2O. 
Phosphorelays are a more complex variation of TCSs in which phosphotransfer follows 
an ATP ! His1 ! Asp1 ! His2 ! Asp2 pathway (30, 45).  Bacteria contain some of the most 
well characterized phosphorelays (68, 70, 79, 80) and the vast majority of TCSs found in plants 
and fungi are phosphorelays (45).  In phosphorelays, the sensory HK (His1) transfers the 
phosphoryl group to a RR receiver domain (Asp1) that does not have an output function.  The 
phosphoryl group is then transferred to His2 on a histidine-containing phosphotransfer domain 
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(Hpt), and then to a RR (Asp2), which executes the output response.  In phosphorelays, signal 
termination often occurs by reverse phosphotransfer (Asp2 ! His2 ! Asp1 ! H2O) (68, 80).  
In contrast to canonical TCSs, phosphotransfer from Asp ! His is essential for function in 
phosphorelays. 
Optimal functioning of any TCS requires meticulous regulation of the flow of phosphoryl 
groups on and off of RR(s).  In phosphorelays, the varied kinetics and directionality of 
phosphotransfer for different Hpt/RR pairs (81) reflects multiple roles for Hpt domains in 
directing phosphoryl group flow.  In addition to acting as both the source and recipient of RR 
phosphoryl groups, some Hpts can transfer phosphoryl groups to three RRs, to provide a branch 
point in a signaling circuit (33, 45), or bind to a RR-P to prevent its dephosphorylation (69).  
Bidirectional phosphotransfer to one response regulator and unidirectional phosphotransfer to 
another response regulator allows the second response regulator to act as a phosphate sink for the 
first (67).  The structural determinants, of either Hpts or RRs, that underlie the variation in 
directionality and kinetics of phosphoryl group flow are not currently known.  In particular, 
protein determinants that favor or disfavor Asp ! His phosphotransfer have not been elucidated. 
Small molecule analogs of phosphoproteins have been extremely useful in probing the 
catalytic contributions of protein components in His ! Asp phosphotransfer.  Two small 
molecule phosphodonors, monophosphoimidazole (MPI) and phosphoramidate (PAM), represent 
progressively reduced portions of the His-P side chain.  The observation that RRs can 
autophosphorylate with small molecule phosphodonors demonstrated that RRs contain the core 
catalytic machinery for His ! Asp phosphotransfer (34).  Small molecule phosphodonors have 
been used to assign the additional catalytic contributions of HKs (82), the RR linker and effector 
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domains (83), and the global conformation of the receiver domain (84) in His ! Asp 
phosphotransfer. 
Here we show that imidazole, the functional group of His, acts as a rudimentary Hpt in 
Asp ! His phosphotransfer.  Imidazole accelerated the dephosphorylation, when compared to 
autodephosphorylation with water, of RRs CheY and PhoB by nucleophilic attack on the 
phospho-Asp.  When imidazole was used in place of an Hpt in an artificial phosphorelay, 
phosphotransfer between non-partner protein components was achieved.  Determination of a co-
crystal structure showed that imidazole orients in the RR active site similarly to the His of an Hpt 
poised for attack on the phospho-Asp.  The imidazole interacted with nonconserved residues in 
the RR active site, and altering those amino acids changed the relative reactivities of a 
phosphorylated RR toward imidazole and water.  The discovery that imidazole is a recipient in 
phosphotransfer from RRs suggests that RRs contain the core catalytic machinery for Asp ! His 
phosphotransfer and opens up potential avenues to dissect Asp ! His phosphotransfer.  
Quantitative comparison of phosphotransfer reactions between various RRs and either Hpts or 
imidazole indicated that although the RR is the primary catalyst and dictated at least some of the 
preference displayed by a particular Hpt for different RRs, the Hpt is essential for high affinity 
binding between reactants and the primary contributor to overall reaction speed. 
3.3 MATERIALS AND METHODS 
3.3.1 Mutagenesis and protein purification. Untagged versions of Escherichia coli wild 
type CheY (CheYwt), CheY F14E N59M E89R (CheYlarge), and CheY F14Q N59K E89Y 
(CheYMPI), and CheA were purified as described (52, 57).  The plasmids encoding His6-tagged 
CheY N59A E89A (CheYsmall), CheY N59Q E89F (CheYSLN1), CheY N59Q E89S (CheYSSK1), 
CheY N59V A88G E89N (CheYSKN7) were made using QuikChange (Agilent) with pKC1 (63) 
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as template.  CheYsmall, CheYSLN1, CheYSSK1, CheYSKN7 were purified as described (51) and 
removal of the His6-tag by thrombin cleavage left three additional residues (GSH) on the N-
terminus.  Additional N-terminal residues do not affect CheY autodephosphorylation (51) or 
autophosphorylation (63).  His6-tagged fusions of E. coli PhoR193-431 and PhoB1-127 (wild type 
and F20D) were purified as described (63).  The His6-tag was cleaved from wild type PhoB1-127 
leaving an additional (GSH) at the N-terminus and PhoB1-127 F20D was used with the His6-tag 
intact.  The F20D substitution prevents formation of a non-physiological dimer of PhoB (65). 
PhoB F20D exhibits autophosphorylation and autodephosphorylation properties 
indistinguishable from wild type PhoB (63, 85).  However, phosphotransfer from PhoR and 
PhoR-phosphatase susceptibility are diminished (85).  All proteins were purified using size 
exclusion chromatography as a final step to remove cleaved peptides, imidazole, and other 
impurities. 
3.3.2 CheY dephosphorylation rate constant measurement by 32P.  The effect of 
imidazole on CheY dephosphorylation was probed with modifications of a previously described 
method for measuring RR autodephosphorylation by following the loss of 32P (51).  Purified 
[32P]CheA-P (1.5 µM) was mixed with CheY (15 µM) in 35 mM Tris at pH 7.5 and 10 mM 
MgCl2. After 10 s, to allow for sufficient phosphotransfer, imidazole was added.  For 
determination of pH-dependence of the imidazole-mediated dephosphorylation reaction, 250 mM 
imidazole was added at pH 4.9 (buffered with 250 mM sodium acetate) or pH 8.2 (buffered with 
250 mM Tris).  For determination of dephosphorylation rate constants of CheYMPI and CheYSKN7, 
the ratio of CheY (30 µM) to [32P]CheA-P (0.30 µM) was increased to allow for rapid 
phosphotransfer.  The phosphotransfer buffer was 5 mM Tris at pH 7.5 and 10 mM MgCl2.  Next, 
imidazole (20 µM - 20 mM for CheYMPI, 2.5 mM – 50 mM for CheYSKN7) was added in 100 mM 
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sodium bicarbonate at pH 10.3.  Autophosphorylation with MPI is negligible at pH 10.3 (64).  
For experiments with CheYMPI under conditions that allowed for simultaneous phosphorylation 
and dephosphorylation, measurements were completed at pH 7.5 with 30 µM CheYMPI, 0.30 µM 
[32P]CheA-P, and 50 mM imidazole (brought to pH 7.6 using HCl) in 35 mM Tris at pH 7.5 and 
10 mM MgCl2.  For all reactions, the final pH of mixed components was confirmed.  Aliquots 
were removed at designated time points and quenched with an equal volume of 2X SDS sample 
buffer.  Reaction components were separated by SDS-PAGE, and loss of radiolabel from CheY 
was detected using a phosphorimager.  The signals were quantified using pixel volume analysis 
in which the background signal was manually subtracted. The amounts of CheY-P were plotted 
versus time and fit to one phase exponentials, yielding first order rate constants (kobs).  Second 
order rate constants were the slopes calculated by plotting kobs versus imidazole concentration.  
All 32P experiments were completed at room temperature. 
3.3.3 PhoB dephosphorylation assayed by 32P.  [32P]PhoB-P was monitored to 
qualitatively determine whether imidazole accelerated dephosphorylation.  His6-tagged PhoR (4 
µM) was incubated with 0.3 mM [γ-32P]ATP in 35 mM Tris pH 8.0, 3.5 mM MgCl2, and 35 mM 
KCl for 30 minutes at room temperature.  The reaction mix containing [32P]PhoR-P was then 
pipetted onto ~ 200 mL of a Ni-NTA Agarose (Qiagen) slurry (equilibrated in 35 mM Tris pH 
8.0, 3.5 mM MgCl2, and 35 mM KCl buffer) on a 0.22 µm PVDF centrifugal filter column 
(Millipore).  The column was centrifuged, then washed multiple times with PhoR 
autophosphorylation buffer to remove excess ATP.  PhoB (90 µM in 60 µL of PhoR 
autophosphorylation buffer) was added directly to the beads, mixed, and incubated for 5 min on 
the column at room temperature to allow for sufficient phosphotransfer.  The column was 
centrifuged to obtain [32P]PhoB-P.  60 µL of [32P]PhoB-P was mixed with either 20 µL of 2 M 
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imidazole or 20 µL of PhoR autophosphorylation buffer.  Time courses were completed and 
analyzed by electrophoresis and phosphorimaging as described above for CheY. 
3.3.4 TLC analysis of phosphorylated small molecules.  To identify small molecules 
containing [32P]phosphoryl groups in reaction mixtures, components were separated by thin layer 
chromatography (TLC).  For each time point, a 1 mL aliquot was spotted onto cellulose PEI-F 
plates (Baker) and the remainder was used to separate proteins by SDS-PAGE.  The TLC 
running buffer was 0.52 M lithium chloride and 1% (v/v) acetic acid (35).  Plates were air-dried 
and radiolabel was detected using a phosphorimager.  Rf values were calculated and compared to 
Rf values of non-radiolabeled standards visualized by reacting with an assay spray as described 
by Bochner et al. (86).  Rf values for experimental data [0.3 ± 0.001 (SD) for Pi, 0.6 ± 0.02 for 
MPI] were similar to Rf values for standards [0.3 ± 0.02 for Pi, 0.6 ± 0.05 for MPI].  The MPI 
used for a non-radiolabeled standard was synthesized as described (87). 
3.3.5 Artificial phosphorelay.  All of the artificial phosphorelay reactions contained 50 
mM Tris (pH 7.5), 10 mM MgCl2, 30 µM [γ-32P]ATP, and 3 µM His6-PhoR.  In addition, 
reactions contained different combinations of the following: 25 µM His6-tagged PhoB F20D, 25 
µM CheYMPI, and 50 mM imidazole.  Reactions were initiated by the addition of the [γ-32P]ATP 
and incubated for 90 minutes at room temperature before separation by SDS-PAGE.  Radiolabel 
was detected with a phosphorimager.  Control experiments were completed using CheYwt instead 
of CheYMPI. 
3.3.6 Crystallization, data collection, structure solution and refinement.  Crystals of 
the CheYMPI"BeF3-"Mn2+"imidazole complex were made by hanging drop vapor diffusion using 
crystallization conditions similar to those used for CheYMPI"BeF3-"Mn2+ (36). BeF3- binds CheY 
tightly and is a stable phosphoryl group analog that is used because of the rapid 
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autodephosphorylation of CheY.  Although Mg2+ is the physiologically relevant divalent cation, 
Mn2+ supports CheY phosphorylation (63) and dephosphorylation (88).  Each drop contained 1.5 
µL of a mixture containing: 2.1 mg/mL CheYMPI, 1 mM MnCl2, 1 mM BeCl2, 10 mM NaF, and 
200 mM imidazole.  Additionally, each drop contained 1.5 µL of well solution: 100 mM Tris – 
pH 8.4, 2.1-2.4 M ammonium sulfate, and 8% (v/v) glycerol.   
Crystals took several days to a week to grow to maximal size.  Crystals were moved to 
cryprotectant as described previously (36, 89).  The cover slip was moved sequentially to well 
solutions containing the same initial well solutions but with 11% (v/v) glycerol then 15% (v/v) 
glycerol.  The crystals were then flash cooled in liquid nitrogen.  
Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-
BM beamline at the Advanced Photon Source, Argonne National Laboratory.  Data were 
collected at a wavelength of 1 Å. Three datasets were processed automatically using the cmdxds 
tools provided by SER-CAT (90).  Data collection statistics are shown in Table 3.1.  Phases were 
determined by molecular replacement using Phaser-MR from the PHENIX suite (91) using a 
single copy of the structure 3FFW (36) (the structure of CheYMPI in the absence of imidazole) 
with all ligands stripped away.  Two copies of CheYMPI"BeF3-"Mn2+"imidazole were found in 
each asymmetric unit.  The best model and electron density maps were examined using Coot (92).  
After manual intervention by stepped real-space refinement with rotamers and visual inspection, 
computation refinement and automated water additions were performed with phenix.refine (91).  
Following manual intervention with Coot, occupancy refinement was attempted for all ligands 
with BUSTER (93).  BUSTER did suggest a small difference in occupancy for the two 
imidazoles.  Following another cycle of manual intervention, the structure was examined by 
PDB_REDO (94).  Final refined statistics are shown in Table 3.1.  Ramachandran plots show no 
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dihedral angles in disallowed regions.  All three data sets showed nearly identical positioning of 
the imidazoles and showed no significant differences in the protein or ligands.  
3.3.7 CheY dephosphorylation rate constant measurement by pH jump/stopped-
flow fluorescence.  The basic method (51, 82) was developed to measure CheY 
autodephosphorylation kinetics and exploits the strong pH-dependence of RR 
autophosphorylation with PAM (negligible at pH 10.3) coupled with the near pH-independence 
of autodephosphorylation over the same pH range (64). Thus, a rapid jump in the pH of an 
equilibrium solution containing CheY-P and excess PAM at neutral pH results in CheY-P 
autodephosphorylation that can be quantitatively monitored with Trp fluorescence.  Here, we 
measured CheY dephosphorylation rates in the absence and presence of imidazole.  The 
instrument was a Perkin Elmer LS-50B spectrofluorimeter interfaced with an Applied 
Photophysics RX-2000 stopped-flow accessory.  All fluorescence experiments were completed 
at 25o C. One stopped-flow syringe contained 20 mM wild type or mutant CheY and PAM [450 
µM for CheYlarge, 1.4 mM for CheYSLN1, 5 mM for CheYSSK1, 15 mM for CheYwt and CheYsmall] 
in 5 mM Tris at pH 7.5 and 10 mM MgCl2.  PAM is not commercially available and was 
synthesized as described (95).  The different PAM concentrations were chosen in light of 
different rate constants of PAM autophosphorylation (51). The other syringe contained 200 mM 
sodium bicarbonate at pH 10.3 and 0-500 mM imidazole (0-1.0 M imidazole for CheYlarge) or 0-
100 mM hydroxylamine.  Fluorescence traces were fit to a one-phase exponential.  The first 
order rate constants (kobs) thus obtained were plotted versus imidazole concentration and, in all 
cases, the relationship approximated linearity. The slopes of the best-fit lines gave the second 
order rate constants, kdephos,imid.  Dephosphorylation data reported for CheYMPI was determined 
using 32P because CheYMPI exhibited fluorescence characteristics that complicated interpretation 
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of results.  Changes in CheYMPI fluorescence upon pH jump were ~30% of the expected change 
based on autophosphorylation fluorescence traces.  The kobs values for CheYMPI measured by pH 
jump agreed with those determined by 32P at low imidazole concentrations but then appeared to 
saturate at high imidazole concentration.  Therefore, the fluorescence change at high imidazole 
appeared to be dominated by other changes to the environment of the Trp besides the loss of the 
phosphoryl group, which was the focus of this study. 
Dephosphorylation rate constants of CheYSKN7 were determined by 32P because 
autophosphorylation of CheYSKN7 with small molecule phosphodonors was not detectable. 
3.3.8 CheY autophosphorylation rate constant measurement using stopped-flow 
fluorescence.  Autophosphorylation rate constants were measured at 25oC for CheYSLN1 and 
CheYSSK1 using MPI as the phosphodonor as previously described in (57).  The stopped-flow 
syringes contained 1) 5 µM CheY, 100 mM Hepes at pH 7.0, 10 mM MgCl2 and 2) varying 
concentrations of MPI (50 µM – 1.6 mM), 100 mM Hepes at pH 7.0, 10 mM MgCl2, 200 mM 
KCl.  Ionic strength was approximately the same in each experiment. 
3.4 RESULTS 
3.4.1 Imidazole stimulates dephosphorylation of the RR CheY.  Because imidazole is 
the functional group of His, there was reason to speculate that imidazole would react with 
phosphorylated RRs.  To determine whether imidazole affects dephosphorylation of CheYwt-P, 
loss of [32P]CheY-P was followed (Fig. 3.1A).  In the absence of imidazole, dephosphorylation 
occurred with a half-life of ~15 s, consistent with CheY autodephosphorylation (96).  In the 
presence of 100 mM imidazole, loss of 32P was considerably faster (half-life < 2 s) than the 
autodephosphorylation of CheY.  These results were confirmed by monitoring a unique Trp in 
the CheY active site (34).  Fluorescence time courses that monitored CheY-P dephosphorylation 
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showed that the presence of imidazole enhanced the rate relative to CheY-P 
autodephosphorylation (Fig. 3.1B). 
3.4.2 Imidazole enhances dephosphorylation by acting as a nucleophile.  Two 
possible mechanisms were considered for the observed acceleration of CheY-P 
dephosphorylation with imidazole.  First, imidazole could act to enhance the known hydrolysis 
reaction, producing Pi – the same product as autodephosphorylation.  Precedence for this 
mechanism is provided by RR phosphatases, which enhance hydrolysis by orienting the 
attacking water molecule (39, 40, 43, 47, 97).  Alternatively, imidazole could act as the 
nucleophile in the reaction, producing MPI.  To determine the mechanism of acceleration of 
CheY-P dephosphorylation, [32P]-small molecule reaction products were analyzed by thin-layer 
chromatography (TLC).  [32P]MPI was produced in the presence of imidazole (Fig. 3.2A), 
consistent with imidazole acting as the nucleophile. 
Nucleophilic activity of imidazole is pH-dependent (98, 99).  At a pH below the pKa of 
6.0, imidazole is mostly protonated and unable to act as a nucleophile.  Above the pKa, imidazole 
is mostly deprotonated and able to act as a nucleophile.  Imidazole was added to [32P]CheY-P 
either at pH 4.9 or at pH 8.2.  The samples were separated using SDS-PAGE (to follow 
[32P]CheY-P) or by TLC (to follow 32P-labeled small molecules).  At pH 4.9, there was no 
enhancement of CheY dephosphorylation by 250 mM imidazole (half life ~ 20 s-1; similar to 
autodephosphorylation), and the amount of [32P]MPI produced was barely detectable above 
background (Fig. 3.2B-C).  In contrast, at pH 8.2, dephosphorylation was enhanced by imidazole 
(half life < 2 s) and [32P]MPI was detected. 
To test whether another nucleophile could enhance dephosphorylation of CheYwt to the 
same extent as imidazole, dephosphorylation was measured in the presence of hydroxylamine.  
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Hydroxylamine is a highly reactive nucleophile towards acyl phosphates (38) and could 
potentially rapidly dephosphorylate CheY-P.  Monitoring CheY-P dephosphorylation by pH-
jump fluorescence, hydroxylamine did not accelerate dephosphorylation of CheY-P to the same 
extent as imidazole (Fig. 3.3A). 
3.4.3 Imidazole-mediated dephosphorylation requires the intact RR active site.  To 
further characterize the reaction of CheY-P with imidazole and probe its generality to other RRs, 
multiple experiments were completed.   
Imidazole can act as a nucleophile against acyl phosphates in the absence of protein or 
other catalyst (38).  To test whether the dephosphorylation reaction with imidazole was 
dependent on catalysis by the folded CheY protein, the dephosphorylation reaction of denatured 
CheY-P with imidazole was assessed.  Imidazole (250 mM) was incubated for 40 minutes with 
[32P]CheY-P that had been denatured in 2% SDS.  Subsequent analysis by phosphorimaging (Fig. 
3.3B) showed no detectable loss of [32P]CheY-P relative to a control that did not contain 
imidazole.  Thus, the reaction between CheY-P and imidazole required folded CheY-P protein. 
In contrast, hydroxylamine (250 mM), which reacted only weakly with folded CheY-P (Fig. 
3.3A) completely dephosphorylated denatured [32P]CheY-P (Fig. 3.3B), likely due to increased 
solvent exposure of the acyl phosphate group. 
The requirement for folded protein for the reaction of CheY-P with imidazole suggested 
that additional features of the RR active site might be required.  RR dephosphorylation by 
hydrolysis requires an active site divalent metal ion such as Mg2+ (88, 96).  Removal of the metal 
inhibits both autophosphorylation and autodephosphorylation.  To determine whether the metal 
is required for dephosphorylation with imidazole, the Trp fluorescence of CheY was monitored 
during addition of various chemicals.  CheY-P was generated by incubating 12 µM CheY with 
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20 mM PAM in 50 mM Tris 7.5 and 14 mM MgCl2.  The metal was then removed from the 
active site of CheY-P by addition of 250 mM EDTA.  Next, 1.1 M imidazole was added, which 
resulted in only minimal dephosphorylation (data not shown).  The little dephosphorylation that 
did occur was likely due to some small portion of CheY-P remaining metal bound.  Rapid 
dephosphorylation (~2 s half life, faster than the reaction with water) occurred when the system 
was replenished with 440 mM Mg2+.  Thus, Mg2+ is also required for catalysis of the reaction 
between imidazole and CheY-P. 
As the functional group of His, imidazole could be a moiety recognized by RRs in 
general.  To probe for generality, another RR, PhoB-P, was reacted with imidazole.  500 mM 
imidazole enhanced [32P]PhoB-P dephosphorylation by at least 10-fold (Fig. 3.4A) suggesting 
that imidazole can react with  RRs in general.   
Finally, because imidazole undergoes nucleophilic attack on phosphoramidates (87, 99), 
we tested whether imidazole reacted with the His-P of an HK.  The HK [32P]CheA-P (1 µM) was 
incubated with 0-500 mM imidazole in 5 mM Tris pH 7.5 and 10 mM MgCl2.  After an hour-
long incubation with imidazole, loss of [32P]CheA-P was not detectable (Fig. 3.4B).  The data 
described above indicate that the intact RR active site is required for dephosphorylation with 
imidazole. 
3.4.4 Phosphoryl groups reversibly transfer between CheYMPI and imidazole.  In the 
experiments described so far, imidazole-mediated RR-P dephosphorylation was observed under 
essentially irreversible reaction conditions that (by choice of pH and/or CheY variant) precluded 
significant re-phosphorylation of CheY.  To further characterize the relationship between RRs 
and imidazole, reactions were carried out under conditions that did not inhibit CheY re-
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phosphorylation with the MPI product.  CheYMPI was chosen for this analysis because it is a 
variant that previously exhibited enhanced ability to autophosphorylate with MPI (57).   
Paradoxically, [32P]CheYMPI-P persisted longer in the presence than in the absence of 
imidazole; 50 mM imidazole increased the apparent half-life by nearly three fold (~21 minutes) 
(Fig. 3.5) compared to the half-life in the absence of imidazole [~8 minutes (52)].  Conversely, 
the apparent half-life of [32P]CheYwt-P was decreased when imidazole was added under similar 
conditions (Fig. 3.1A).  TLC analysis of the reaction of CheYMPI-P with imidazole showed a 
rapid burst of [32P]MPI followed by the gradual consumption of [32P]MPI and accumulation of 
[32P]Pi (Fig. 3.5) - consistent with three reactions proceeding simultaneously.  Starting with 
[32P]CheYMPI-P, imidazole rapidly dephosphorylated [32P]CheYMPI-P, producing a burst of 
[32P]MPI (Fig. 3.5).  CheYMPI was able to then re-phosphorylate to form [32P]CheYMPI-P, 
consuming the [32P]MPI.  Subsequently, some [32P]CheYMPI-P was able to autodephosphorylate 
resulting in the accumulation of [32P]Pi.  Because CheYMPI autophosphorylates with MPI (57) 
much faster than it dephosphorylates with imidazole or water, the [32P]CheYMPI-P persisted 
longer than in the absence of imidazole. 
3.4.5 Imidazole can act as a rudimentary Hpt in an artificial phosphorelay.  The 
reversible phosphotransfer between CheYMPI and imidazole is analogous to reversible transfer 
between RRs and Hpts, and suggests that imidazole may be able to function in a manner 
reminiscent of an Hpt in a phosphorelay.  An artificial phosphorelay was designed to test 
whether imidazole could transfer phosphoryl groups between different response regulators.  To 
probe the robustness of such an ability, instead of just replacing the Hpt of a known 
phosphorelay with imidazole, the artificial phosphorelay was assembled from components that 
are not part of natural phosphorelays.  Following progressive inclusion of phosphorelay 
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components, transfer of phosphoryl groups was tracked (Fig. 3.6A).  The PhoR193-431 HK 
cytoplasmic fragment was incubated with [32P]ATP, resulting in [32P]PhoR-P (lane 1).  When 
PhoR partner RR PhoB1-127 F20D was added, phosphorylation of PhoB F20D was observed as 
expected (lane 2).  His6-tagged PhoB1-127 F20D was used for clean separation from PhoR193-431 
and CheYMPI on SDS-PAGE.  When imidazole was added, there was a loss of [32P]PhoB F20D-P 
(lane 3), consistent with phosphotransfer from PhoB F20D to imidazole.  If non-partner RR 
CheYMPI was added in the absence of imidazole, then the [32P]PhoB F20D-P remained and 
accumulation of [32P]CheYMPI-P was not detected (lane 4).  However, if CheYMPI was added in 
the presence of imidazole, both loss of [32P]PhoB F20D-P and accumulation of [32P]CheYMPI-P 
were observed (lane 5).  Thus, in the presence of imidazole, CheYMPI becomes phosphorylated 
though sequential phosphotransfer from ATP ! PhoR ! PhoB ! imidazole ! CheYMPI.  
Control experiments for the artificial phosphorelay revealed that, under normal 
experimental conditions, CheYMPI was directly phosphorylated by PhoR (Fig. 3.6B).  PhoB 
F20D had to be absent in order for crosstalk between PhoR and CheYMPI to occur (cf. lane 4 of 
Fig. 3.6A and Fig. 3.6B).  Additionally, crosstalk was not observed between PhoR and CheYwt 
under the same conditions (data not shown).  The ability of CheYMPI to accept phosphoryl groups 
from a non-partner HK is consistent with CheYMPI having an enhanced affinity for the 
phosphorylated imidazole (MPI) moiety (57).   
3.4.6 Nonconserved residues D+2, T+1, and T+2 interact with imidazole ring in the 
response regulator active site.  To further explore the basis by which imidazole could act 
similarly to an Hpt in reactions with CheYMPI-P, three crystal structures of CheYMPI in complex 
with Mn2+, the stable phosphoryl group analog BeF3-, and imidazole were determined to a 
resolution of 1.9-2.1Å (Table 3.1).  To our knowledge, these represent the first structures of an 
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activated response regulator complexed with a small molecule phosphoacceptor.  Two 
imidazoles were found complexed with each of the two CheYMPI per asymmetric unit (Fig. 3.7A).  
However, the linear dependence of CheY-P dephosphorylation on imidazole concentration (Fig. 
3.3A for wildtype CheY and data not shown for other CheY variants) strongly suggests that only 
one of the two imidazoles is involved in the dephosphorylation reaction.  One imidazole, at full 
occupancy but likely irrelevant to the dephosphorylation reaction, was coordinated with the Mn2+, 
consistent with the affinity between imidazoles and transition metals exploited in the use of His-
tagged proteins and Ni-affinity column (100).  The other imidazole, at partial occupancy, was 
positioned over the phosphomimic oriented for direct in-line attack of the phosphoryl group (Fig. 
3.7).  For six individual CheYMPI monomers, the closest atom from the imidazole was 3.4 ± 0.2 
Å from the beryllium, consistent with the ability reported here of imidazole to dephosphorylate 
response regulators.  Despite the lower occupancy of the imidazole poised for nucleophilic attack, 
clear electron density for the plane of the imidazole was observed in all three independent 
structures (Fig. 3.7B).  Furthermore, when the CheYMPI"BeF3-"Mn2+"imidazole structure was 
overlaid (Fig. 3.8) with two activated RR/Hpt complexes – SLN1"BeF3-"Mg2+"YPD1 (PDB 
2R25) (101) and Spo0F"BeF3-"Mg2+"Spo0B (PDB 2FTK) (102) – the imidazole in the CheYMPI 
active site was oriented similarly to the imidazole moieties of the Hpt (YPD1 and Spo0B) 
histidines; all were positioned for in-line attack.   
For the CheYMPI"BeF3-"Mn2+"imidazole structures (PDB 5D2C, 5DGC, 5DKF), residues 
at positions D+2 (two positions C-terminal to the site of phosphorylation, K in CheYMPI), T+1 
(one position C-terminal to the conserved Thr/Ser, A in CheYMPI), and T+2 (two positions C-
terminal to the conserved Thr/Ser, Y in CheYMPI) were in direct contact with the imidazole 
through van der Waal’s interactions.  Similar interactions were observed between residues at 
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D+2, T+1, and T+2 on the SLN1 receiver domain and the histidine of YPD1.  In both cases, non-
conserved active site residues at D+2, T+1, and T+2 formed a discrete pocket around the 
imidazole (Fig. 3.8A). These observations suggest a role for non-conserved active site residues in 
RRs in the reaction with imidazole, and, potentially, with Hpts.  This is direct evidence that 
imidazole is able to fulfill some of the function of an Hpt in a similar fashion to the Hpt.  
3.5.7 Non-conserved active site residues influence dephosphorylation with imidazole.  
Active sites of RRs consist of five conserved residues and several residues that vary amongst 
different RRs (23).  Non-conserved active site residues modulate autophosphorylation (57) and 
autodephosphorylation (36, 52) of RRs.  Because structural analysis of CheYMPI complexed with 
imidazole, as well as of the SLN1 receiver domain complexed with the YPD1 Hpt protein, 
showed that non-conserved residues at D+2, T+1, and T+2 could facilitate appropriate 
orientation of the imidazole in the active site, it seemed logical that these three residues might 
influence the rates of dephosphorylation with imidazole. Ala occupies position T+1 in about half 
of response regulators, so dephosphorylation rate constants with imidazole were measured for a 
set of CheY mutants containing Ala at T+1 and various substitutions at D+2 and T+2. The initial 
set of mutants explored four distinct active site environments: CheYwt contains the polar amino 
acids Asn at D+2 and Glu at T+2.  CheYsmall represents a reduced active site in which the D+2 
and T+2 residues are both Ala.  With CheYlarge, a previously solved crystal structure indicates 
that the large Met and Arg side chains (D+2 and T+2, respectively) could potentially occlude the 
active site, hindering interaction between the nucleophile and the phospho-Asp (36).  CheYMPI 
(Lys at D+2 and Tyr at T+2) is highly reactive with MPI [103-fold faster autophosphorylation 
than CheYwt (57)], possibly reflective of enhanced affinity for the imidazole moiety.  Rate 
constants for imidazole-mediated dephosphorylation of these four CheY variants varied over a 
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~20-fold range (Table 3.2). Similarly, autodephosphorylation rate constants of this mutant set 
span a ~30-fold range; however, the rank order from fastest to slowest varied considerably for 
imidazole versus water-mediated dephosphorylation.  For the mutants studied here, the relative 
sensitivity to imidazole, defined by the ratio of imidazole-mediated to water-mediated 
dephosphorylation rate constants, varied over a 100-fold range. All of the CheY-P variants were 
at least 1000-fold more reactive with imidazole than with water.  The differences in reactivity 
were potentially due to the chemical properties of imidazole and/or due to features of the RR 
active site.  
3.4.8 Non-conserved active site residues influence phosphorylation reactions in 
CheY variants that mimic phosphorelay receiver domains.  Considering the previous results 
that imidazole could function in some ways similarly to an Hpt, we next used imidazole as a tool 
to dissect the contributions of response regulator and Hpt proteins to Asp ! His phosphotransfer 
reactions.  To our knowledge, the yeast osmosensing phosphorelay is the only phosphorelay 
system for which rate constants have been measured for His ! Asp and Asp ! His 
phosphotransfer events (81).  The system contains one Hpt, YPD1, which interacts with three 
different receiver domains: SLN1, SSK1, and SKN7.  YPD1 reacts differentially with each 
receiver domain (Tables 3.3 & 3.4) such that phosphotransfer is: rapid in both directions with 
SLN1, rapid to SSK1 and does not occur from SSK1 to YPD1, and slow in both directions with 
SKN7.  Although phosphotransfer rate constants varied between YPD1 and each of the receiver 
domains, binding constants were similar (1.4-7.8 µM (81)), suggesting that the variation in 
phosphotransfer arises from the reaction chemistry.  Because the three receiver domains all react 
with the same Hpt, it is logical to hypothesize that the receiver domains, and not the Hpt, contain 
the determinants of the relative reactivities.  Alternatively, the differential reactivities may arise 
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due to differences in interactions between the Hpt and each of the receiver domains; for example, 
binding may not align reactants optimally.  We predicted that, based on the first hypothesis, 
reactions between RR-P and imidazole (analogous to Asp ! His phosphotransfer) or between 
MPI and RR (His ! Asp) would reflect the relative reactivities observed in the yeast system.  
Based on the CheY"BeF3-"Mn2+"imidazole structure, variants of CheY were made that matched 
the three yeast receiver domains at the three non-conserved residues at D+2, T+1, and T+2, 
which interacted with the imidazole ring in both the CheY and SLN1 structures. Additionally, 
the CheY variants match the yeast receiver domain active sites at conserved residues D (site of 
phosphorylation), T, K, and the two acids that coordinate the divalent metal (DD in CheY, ED in 
the yeast receiver domains).   
Relative to each other, the yeast receiver domains SLN1 and SSK1 were faster than 
SKN7 for His ! Asp phosphotransfer (81).  Similarly, CheYSLN1 and CheYSSK1 were faster than 
CheYSKN7 for autophosphorylation with MPI (Table 3.3).  In fact, autophosphorylation of 
CheYSKN7 with MPI (or two other small molecule phosphodonors, PAM and acetyl phosphate) 
was not detectable. To determine whether the failure of CheYSKN7 to autophosphorylate was a 
meaningful result or the trivial consequence of a nonfunctional protein, other activities of 
CheYSKN7 were assayed.  Binding of Mg2+ (required for catalysis (88)) to CheYSKN7 was detected 
using fluorescence quenching (data not shown) and CheYSKN7 was phosphorylated in the 
presence of CheA and [32P]ATP (data not shown), indicating that CheYSKN7 is properly folded. 
For Asp ! His phosphotransfer, SLN1 transfers more rapidly than SKN7 to YPD1 
(Table 3.4) (81).  Asp ! His phosphotransfer was not observed for SSK1-P and YPD1 (81).  
This is likely due to formation of an inhibitory YPD1•SSK1-P complex that results in a ~200x 
reduction in autodephosphorylation of SSK1-P (i.e. reaction with water), presumably by steric 
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occlusion of the active site.  Consistent with comparisons between SLN1 and SKN7, CheYSLN1 
was faster than CheYSKN7 for dephosphorylation with imidazole – though the difference was 
modest (Table 3.4). 
Taken together, the results reported in Tables 3.3 and 3.4 indicate that the receiver 
domain active site provides at least some of the determinants for the relative preferences in 
phosphotransfer reported between the YPD1 Hpt protein and the SLN1, SSK1, and SKN7 
receiver domains. 
3.5 DISCUSSION 
3.5.1 Phosphotransfer reactions in TCSs: Hpt domains allow bidirectional His/Asp 
phosphotransfer.  To provide context for thinking about potential implications of the reactions 
of imidazole characterized here, we first summarize the phosphotransfer reactions known to 
occur in TCS proteins.  Recall that HK DHp (dimerization and histidine phosphotransfer) 
domains and Hpt domains are phosphorylated on His residues, whereas RR proteins are 
phosphorylated on Asp residues. Therefore, in the ATP ! HK DHp ! RR ! H2O 
phosphotransfer pathway of canonical TCSs, the phosphotransfer between HKs and RRs is His 
! Asp.  Although phosphotransfer from RR ! HK DHp has been observed in vitro (103, 104), 
the physiologically relevant reaction between most HKs and RRs is believed to be unidirectional 
from HK ! RR (see exception below).  The inclusion of Hpt domains, however, which 
participate in bidirectional phosphotransfer, allows more complex phosphorelays. The typical 
phosphotransfer pathway in a phosphorelay is ATP ! HK ! RR1 ! Hpt ! RR2 ! Hpt ! 
RR1 ! H2O (79, 105). Thus, in addition to the HK DHp! RR phosphotransfer utilized in 
canonical TCSs, phosphorelays require a second type of His ! Asp phosphotransfer (Hpt ! 
RR), as well as Asp ! His (RR ! Hpt) phosphotransfer for function.  In CheA-type HKs, the 
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DHp domain of a canonical HK is replaced by an Hpt domain (106).  The ability of Hpt domains 
to support bidirectional phosphotransfer can then allow reverse phosphotransfer from one RR 
through CheA to another RR that acts as a phosphate sink (67): ATP ! Hpt ! RR1 ! Hpt ! 
RR2 ! H2O. 
3.5.2 Small molecule analogs as kinetic probes of TCSs.  Autophosphorylation of RRs 
with PAM and MPI, small molecule analogs of phospho-His, has long been informative for 
dissecting catalytic contributions to His ! Asp (HK DHp ! RR or Hpt ! RR) phosphotransfer 
reactions (57, 64, 83).  The imidazole-mediated dephosphorylation of RR-P reported here (RR-P 
+ imidazole ! RR + MPI) is the reverse of the autophosphorylation reaction with MPI.  
Analogously, this reaction is informative for the kinetic dissection of Asp ! His phosphotransfer, 
which is characteristic of phosphorelays. 
The reaction rates of a single Hpt protein for both His ! Asp and Asp ! His 
phosphotransfer can differ dramatically with different RRs (81).  The determinants contained in 
either Hpts or RRs that underlie the variation in kinetics, specificity, and directionality of Hpt 
#! RR phosphotransfer reactions are not known.  Here, we explore the use of imidazole to 
probe Asp ! His phosphotransfer.  Additionally, we used MPI to probe His ! Asp 
phosphotransfer in the context of phosphorelays. 
3.5.3 Receiver domain active sites account for some kinetic preference in 
phosphotransfer reactions involving Hpts.  Comparing the properties of a phosphotransfer 
reaction between two proteins with a reaction in which one protein is replaced with a small 
molecule allows us to ask what the remaining protein can contribute to the reaction.  Thus, in 
principle, replacement of an Hpt with imidazole could be used to assess the contributions of a 
RR to a RR-P ! Hpt reaction.  The fact that the reaction with imidazole occurred at all is 
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evidence that the RR provides the core catalytic machinery for the chemistry (see section below).  
But the availability of co-crystal structures between CheY, BeF3-, and imidazole (Fig. 3.7) 
allowed us to go further in dissecting contributors to the RR-P ! Hpt reaction.  Because the 
structure of CheYMPI complexed with imidazole revealed interactions between imidazole and 
non-conserved active site residues at D+2, T+1, and T+2, we could assess the contributions of 
the active site portion of the RR in regulating the degree of catalysis.  We constructed three 
chimeric proteins, in which the active sites of three yeast response regulators were spliced onto 
the same RR backbone, CheY.  The CheYSLN1, CheYSSK1, and CheYSKN7 chimeras matched the 
wild type yeast receiver domains at four out of five conserved active site residues (one of the 
conserved metal-coordinating acid residues was a D in CheY instead of the E found in the yeast 
RRs) as well as the three non-conserved positions.  If the relative kinetics of the chimeras 
correlated with the relative kinetics of the yeast proteins, it could be concluded that differences in 
the RR active sites contribute to modulation of the variable kinetics in the yeast system. 
The kinetics of phosphotransfer between the YPD1 Hpt and the three yeast receiver 
domains are saturable, allowing the measurement of binding constants (Kd) and first-order 
kinetic constants for catalysis (kmax) (81).  In contrast, reactions between CheY and small 
molecules are not saturable at experimentally accessible concentrations (107), so only 
bimolecular rate constants incorporating both binding and catalysis were obtained.  For "Asp ! 
His" phosphotransfer, CheYSLN1-P ! imidazole was faster than CheYSKN7-P ! imidazole (Table 
3.4), just as SLN1-P ! YPD1 is faster than SKN7-P ! YPD1 (81).  However, the difference in 
rate constants for the model reactions of CheY chimeras with imidazole was a modest four-fold, 
whereas the difference in kmax for the phosphotransfer reactions between yeast RR-P and Hpt 
proteins was 70-fold.  This suggests that the non-conserved active site residues in the receiver 
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domains contribute to, but do not entirely account for, the differential reactivities for Asp ! His 
phosphotransfer observed in the yeast phosphorelay.   
For "His ! Asp" phosphotransfer, rate constants for transfer from MPI to CheYSLN1, 
CheYSSK1, or CheYSKN7 resulted in the same rank order as rate constants (kmax) for 
phosphotransfer from YPD1-P to SLN1, SSK1, or SKN7 (Table 3.3).  In contrast to the Asp ! 
His results, in this case, the rate constants (kphos/Ks) for the CheY chimeras spanned a range of 
more than three orders of magnitude, whereas the rate constants for the yeast receiver domains 
span two orders of magnitude.  The correlation is consistent with the notion that the receiver 
domain non-conserved active site residues strongly contribute to the differential activities of 
multiple RRs with a single Hpt in His ! Asp transfer. 
3.5.4 RRs contain the primary catalytic machinery for Asp to His phosphotransfer.  
In Asp ! His phosphotransfer, the His residue on the Hpt acts as a nucleophile to attack the 
phospho-Asp on the RR-P, resulting in unphosphorylated RR and Hpt-P (80, 81).  In analogous 
fashion, imidazole was able to accept phosphoryl groups from both CheY-P and PhoB-P, 
resulting in unphosphorylated RR and MPI (Figs. 2, 4, 5 & 6).  Analogous to an Hpt, imidazole 
was able to reversibly transfer phosphoryl groups with CheYMPI (Fig. 3.5) and acted in place of a 
His2 in an artificial phosphorelay (Fig. 3.6).  Dephosphorylation of RRs with imidazole requires 
the intact RR active site, but does not require input from other proteins.  Previous work 
established that RRs contain the catalytic core of His ! Asp (34, 64) and Asp ! H2O (47, 96) 
phosphotransfer reactions.  Zhao, et al. proposed that, in order to catalyze the phosphotransfer 
chemistry between Hpts and RRs, the RR conserved active site residues and divalent active site 
metal interact with the equatorial oxygens of the phosphoryl group, stabilizing the proposed 
trigonal bipyramidal transition state [Fig. 3.7 of (101)].  The ability of RRs studied here to 
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achieve phosphotransfer to imidazole in a fashion that required the intact metal-bound RR active 
site provides functional evidence that RRs are sufficient for catalysis of Asp ! His 
phosphotransfer.   
The ability of RRs to support reactions with imidazole and MPI, i.e. support 
phosphotransfer reactions in the absence of a protein partner, is consistent with the assertion (4) 
that Hpt active sites have minimal known catalytic features beyond the phosphorylatable His.  
For Hpt domains that constitute the phosphorylation site of CheA-type HKs, several amino acids 
that form a hydrogen bonding network with the His are critical for phosphorylation with ATP 
(108).  However, alteration of similar residues in YPD1 had only modest effects on 
phosphotransfer reactions with SLN1 (45, 81, 109).  Replacement of a particular Gly with a 
larger residue had a substantial effect on the ability of YPD1 to support phosphotransfer, 
presumably due to blocking access of the receiver domain to the YPD1 His (45).  In summary, 
there does not appear to be compelling evidence that specific Hpt residues other than the His 
make important contributions to catalysis of phosphotransfer with RRs. 
Although not a primary contributor of catalytic machinery, Hpt proteins clearly do make 
important contributions to phosphotransfer reactions with RRs.  The bimolecular rate constants 
for phosphotransfer between CheY and imidazole/MPI are many orders of magnitude slower 
than the corresponding rate constants for phosphotransfer between the yeast RRs and YPD1 
(Tables 3.3 & 3.4).  One means by which Hpts enhance phosphotransfer is through binding 
between phosphodonor and recipient through protein-protein interactions.  Additionally, the Hpt 
domain could possibly enhance phosphotransfer by (i) orienting the His in the active site and/or 
(ii) acting as a cap and excluding water from the RR active site. 
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3.5.5 Imidazole orients similarly to Hpts in Asp ! His phosphotransfer.  
Biochemical analysis of reactions between CheY-P (and PhoB-P) and imidazole showed the 
capability of the receiver domains to support Asp ! His phosphotransfer.  To explore the model 
reaction further, we determined the structure of CheYMPI complexed with imidazole and BeF3- 
(Fig. 3.7) and compared it to the few reported structures of HKs or Hpts complexed with RRs 
and a phosphoryl group or phosphomimic.  In the available structures of HK-P•RR (PDB 3KYI) 
or HK•BeF3-•RR (PDB 4JAV) complexes, the His and Asp residues are not oriented to react with 
one another.  We are aware of two co-crystal structures of RRs complexed with Hpts in the 
presence of a phosphomimic – Spo0F"BeF3-"Mg2+"Spo0B (PDB 2FTK) (102) and SLN1"BeF3-
"Mg2+"YPD1 (PDB 2R25) (101).  Note that these structures represent the two known classes of 
Hpt domains.  Both classes form a four-helix bundle, but the Spo0B class is dimeric and 
apparently arose from degenerate HKs (49), whereas more typical Hpt proteins are monomeric 
(110).  When the structure of CheYMPI•BeF3-• Mn2+"imidazole was aligned with each RR•BeF3-
•Hpt co-crystal structure, the imidazole was oriented similarly to the His residues from both 
types of Hpts and positioned appropriately for nucleophilic attack (Fig. 3.8).  In particular, the 
distances from the imidazole ring to the Be atom (P analog) were 3.4 ± 0.2 Å for imidazole alone, 
3.6 ± 0.8 Å (from four separate protamers) for Spo0B, and 3.2 Å for YPD1.   
3.5.6 Non-conserved active site residues differentiate between nucleophiles.  In 
addition to similar orientation of the imidazole ring, alignment of the CheYMPI•BeF3-•imidazole 
structure with two RR•BeF3-•Hpt structures showed that non-conserved active site residues in 
each RR (D+2, T+1, and T+2 in CheY and SLN1; D+2 and T+1 in Spo0F) interacted with the 
imidazole ring and formed a pocket directly over the phosphomimic.  The overall suggestion was 
that non-conserved active site residues at D+2, T+1 and T+2 functioned to orient the imidazole 
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ring in the active site and could potentially influence catalysis.  Residues at these positions 
influence autodephosphorylation reactions in receiver domains (57), so it seemed reasonable to 
predict that residues at D+2, T+1, and T+2 would influence dephosphorylation reactions with 
imidazole.  In this work, imidazole-mediated dephosphorylation of seven CheY variants was 
assessed (Tables 3.2 & 3.4).  Rate constants for water and imidazole-mediated 
dephosphorylation spanned similar ranges – 29 and 33-fold, respectively (Table 3.5).  However, 
rank orders from fastest to slowest were different for water versus imidazole.  As a result, the 
relative sensitivities of the CheY variants to the two nucleophiles spanned a 110-fold range. The 
large range in relative sensitivities suggests that the non-conserved active site residues 
discriminate between water and imidazole as nucleophiles.   
Considering the roles of RRs and Hpts in phosphotransfer reactions, the variation in 
relative sensitivities between CheY variants reported here may reflect some aspect of RR/Hpt 
function in phosphorelays.  From the perspective of Hpts, one function in phosphorelays is to 
react differentially with multiple receiver domains (81) (which we set out to probe with this 
work) while maintaining specificity to protect against cross reactivity with RRs from other TCSs 
in the cell (70) (which we do not address experimentally with this work).  From the perspective 
of RRs, one function in phosphorelays may be to distinguish between phosphotransfer to His or 
to water.  The slowest rate constant measured here for phosphotransfer from a CheY variant to 
imidazole was 1,500 times greater than the rate constant for transfer to water, but some CheY 
variants achieved even greater discrimination between nucleophiles.  When considering ability of 
non-conserved active site residues to influence both water and imidazole-mediated 
dephosphorylation, the CheYsmall variant represents a reduced active site, which we used as a 
convenient reference point for purposes of interpretation.  Conceivably, phosphorelay RRs that 
!! 73 
undergo rapid phosphotransfer to Hpts may represent cases in which reaction with imidazole is 
preferred over autodephosphorylation.  CheY variants that mimic faster phosphorelay RRs - 
CheYMPI (contains same D+2, T+2 residues as phosphorelay RR Spo0F), CheYSLN1, CheYSKN7 – 
exhibit relative sensitivities to imidazole larger than that of CheYsmall.  Consistent with predicted 
behavior, these variants were better at differentiating between water and imidazole.  For CheY 
variants that did not mimic known phosphorelay RRs, relative sensitivities to imidazole were 
smaller.  CheYSSK1 had a relative sensitivity to imidazole that was lower than that of CheYsmall, 
consistent with the observation that SSK1 does not transfer phosphoryl groups to YPD1.  
Notably, CheYwt had the lowest relative sensitivity to imidazole.   
3.5.7 Practical applications of imidazole. In addition to the use of imidazole as an 
experimental tool in the study of TCSs, there are several potential practical applications.  One 
use of imidazole could be ‘partial phosphorelays’ to generate [32P]MPI or [32P]RR-P.  
Radiolabeled MPI is not commercially available and, currently, making [32P]MPI requires 
synthesis of [32P]PAM first.  Using imidazole and RRs could simplify the protocol for the 
generation of radiolabeled MPI.  Currently, radiolabeling RRs typically utilizes a partner HK and 
commercially available [γ-32P]ATP as the phosphodonor. However, HKs are often 
transmembrane proteins, and isolation of catalytically active soluble fragments of HKs can be 
difficult and time consuming.  Using an artificial phosphorelay to radiolabel RRs could eliminate 
the need for isolation and use of the partner HK.  Finally, imidazole could be used to rapidly 
dephosphorylate RRs in vitro.  As a closing note, given the data reported here, it is important to 
eliminate imidazole from His-tagged TCS proteins eluted off of a Ni-column for use in 
phosphorylation studies. 
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3.6 TABLES  
 
 ! !
Table 3.1 Data collection and refinement statistics  
 Crystal 1  
(5d2c) 
Crystal 2 
(5dgc) 
Crystal 3 
(5dkf) 
Data collection    
Space group P212121 P212121 P212121 
Cell dimensions      
    α, β, γ (Å) 53.62, 53.72, 
162.45  
53.49, 53.58, 
161.98 
53.58, 53.74, 
162.61 
    α, β, γ  (°)  90.0, 90.0, 90.0 90.0, 90.0, 
90.0 
90.0, 90.0, 
90.0 
Resolution (Å) 44.8 - 2.06  
(2.11-2.06)* 
26.43 – 1.94 
(1.99 – 1.94) 
81.3 - 1.94 
(1.99 – 1.94)  
Rmerge 0.083 (0.58) 0.119 (0.65) 0.073 (0.623) 
I / σI 15.1 (3.88) 10.4 (2.72) 16.0 (2.84) 
Completeness (%) 97.6 (91.7) 99.7 (99.7) 100.0 (99.6) 
Redundancy 7.2 (7.4) 7.2 (5.7) 7.2 (5.8) 
    
Refinement (Refmac 5.8.0103)   
Resolution (Å) 44.8-2.06 (2.11-
2.06) 
26.43-1.94 
(1.96 - 1.94) 
81.3 - 1.94 
(1.96 – 1.94) 
No. reflections 
(Rwork/Rfree) 
27677/1953 35162/1767 35660/1790 
Rwork / Rfree 16.1/18.5 16.9/18.1 15.7/16.2 
Molecules/AU 2 2 2 
No. atoms    
    Protein 2004 2024 2088 
    Ligand/ion 70 53 82 
    Water 220 245 304 
B-factors    
    Protein 24.1 19.2 8.9 
    Ligand/ion 59.7 45.3 27.3 
    Water 44.1 37.8 33.1 
RMSZ scores#    
    Bond lengths 0.68 0.81 0.81 
    Bond angles 0.78 0.83 0.85 
EDS Fo, Fc correlation 0.95 0.94 0.94 
*Values in parentheses are for highest-resolution shell. 
 # RMSZ is the root-mean-square of all Z scores of the bond lengths (or angles) in the 
structure.  A Z score for a bond length (or angle) is the number of standard deviations the 
observed value is removed from the expected value. A bond length (or angle) with |Z| > 5 
is considered an outlier worth inspection.  
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Table 3.2  Rate constants for dephosphorylation of CheY variants with imidazole and water  
   Relative 
Receiver kdephos,imida kdephos,waterb sensitivity 
domaina (M-1s-1) x10-5 (M-1s-1) to imidazolec 
CheYwt 1.1 ± 0.1 75.0 ± 9.0d 1,500 
CheYsmall 1.2 ± 0.04 9.0 ± 0.6e 14,000 
CheYlarge 0.25 ± 0.005 3.3 ± 0.0d 8,200 
CheYMPI  4.3 ± 0.05 2.6 ± 0.3e 170,000 
aValues are averages of second order rate constants from 2-3 measurements (completed at pH 
10.3) ± SD and are determined by pH-jump fluorescence except CheYMPI was measured using 
32P. 
bCalculated by dividing first order water-mediated dephosphorylation rate constants by the 
concentration of water (55.5 M).   
cRelative sensitivity to imidazole was calculated by dividing kdephos,imid by kdephos,water.   
dFirst order water-mediated dephosphorylation rate constants from (52). 
eFirst order water-mediated dephosphorylation rate constant determined using 32P as previously 
described in (52).   
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Table 3.3  Rate constants for “His ! Asp” phosphotransfer  
  YPD1-P ! yeast RR  MPI ! CheY 
Receiver Amino acid at kmaxa Kda kmax/Kd kphos/KS 
domain D+2 T+1 T+2 (s-1) (µM) (x 106 M-1s-1) (M-1s-1) 
SLN1/CheYSLN1 Q A F 230 ± 130 7.8 ± 5.7 29 750 ± 40 
SSK1/CheYSSK1 Q A S 160 ± 70 2.4 ± 1.9 67 34 ±   6 
SKN7/CheYSKN7 V G N 1.4 ± 0.2 1.5 ± 0.5 0.9 < 0.1b 
aValues are from (81). 
bPhosphorylation with MPI was below the limit of detection by fluorescence quenching.  The 
observed rate of approach to equilibrium is given by kobs = (kphos/Ks)[phosphodonor] + kdephos,water.  
To detect phosphorylation, the term describing the phosphorylation rate (which changes with 
phosphodonor concentration) must be at least as large as the term for dephosphorylation (which 
is invariant).  With [MPI] = 25 mM and kdephos,water for CheYSKN7 = 0.002 s-1, setting the 
phosphorylation and dephosphorylation terms equal gives kphos/KS = 0.08 M-1 s-1. 
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Table 3.4  Rate constants for “Asp ! His” phosphotransfer  
  yeast RR-P ! YPD1  CheY-P ! imidazole 
Receiver Amino acid at kmaxa Kda kmax/Kd kdephos,imidazole 
domain D+2 T+1 T+2 (s-1) (µM) (x 106 M-1s-1) (M-1s-1) 
SLN1/CheYSLN1 Q A F 29  ±  3 1.4 ± 0.6 21 8.2 ± 0.4 
SSK1/CheYSSK1 Q A S -b - - 3.1 ± 0.1 
SKN7/CheYSKN7 V G N 0.4 ± 0.1 5.0 ± 3.0 0.08 1.9 ± 0.4 
aValues are from (81). 
bPhosphotransfer was not observed from SSK1-P to YPD1 (81). 
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Table 3.5  Relative sensitivity of CheY variants for imidazole versus water 
   Relative 
Receiver kdephos,imida kdephos,waterb sensitivity 
domain (M-1s-1) x10-5 (M-1s-1) to imidazolec 
CheYMPI  4.3 ± 0.05 2.6 ± 0.3d 170,000 
CheYSKN7 1.9 ± 0.4 3.9 ± 0.4d 48,000 
CheYSLN1 8.2 ± 0.4 18.0 ± 4.2e 45,000 
CheYsmall 1.2 ± 0.04 9.0 ± 0.6d 14,000 
CheYSSK1 3.1 ± 0.1 34.0 ± 7.2e 9,000 
CheYlarge 0.25± 0.005 3.3 ± 0.0f 8,200 
CheYwt 1.1 ± 0.1 75.0 ± 9.0f 1,500 
aValues are averages of second order rate constants from 2-3 measurements (completed at pH 
10.3) ± SD and are determined by pH-jump fluorescence except CheYMPI and CheYSKN7 were 
measured using 32P. 
bCalculated by dividing first order water-mediated dephosphorylation rate constants by the 
concentration of water (55.5 M).  Multiply column values by 10-5. 
cRelative sensitivity was calculated by dividing kdephos,imid by kdephos,water.   
dFirst order water-mediated dephosphorylation rate constant determined using 32P as previously 
described in (52).   
eFirst order water-mediated dephosphorylation rate constant determined using pH-jump 
fluorescence described in (51). 
fFirst order water-mediated dephosphorylation rate constants from (52). 
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3.7 FIGURES 
 
 
Figure 3.1  CheY-P dephosphorylation kinetics in the absence and presence of imidazole.  (A) 
Phosphorimaging scans of SDS-PAGE gels showing the time-dependent loss of 32P from 
[32P]CheY-P in the absence (top panel) or presence (bottom panel) of 100 mM imidazole at pH 
7.5.  (B) Trp fluorescence time traces showing loss of phosphoryl groups with 0 (black), 50 mM 
(medium gray), or 500 mM (light gray) imidazole at pH 10.3. 
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Figure 3.2  Nucleophilic activity of imidazole in the dephosphorylation of CheY-P.  
Phosphorimaging scans of TLC plate showing products of [32P]CheY-P dephosphorylation 
reactions (A) in the absence or presence of 250 mM imidazole at pH 7.5 and (B) in the presence 
of 250 mM imidazole at pH 4.9 (buffered with 250 mM sodium acetate) or pH 8.2 (buffered with 
250 mM Tris).  (C) Phosphorimaging scans of SDS-PAGE gels showing the loss of 32P from 
[32P]CheY-P in the presence of 250 mM imidazole at pH 4.9 (top panel) or pH 8.2 (bottom 
panel). 
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Figure 3.3  CheY-P dephosphorylation in the presence of imidazole or hydroxylamine.  (A) 
Plots of kdephos versus small molecule concentration showing the enhancement of CheY-P 
dephosphorylation with hydroxylamine (open squares and diamonds) compared to imidazole 
(closed squares and diamonds).  CheY dephosphorylation was measured by stopped-flow 
fluorescence as previously described.  The y-intercepts of each fit are approximately the rate 
constant for water-mediated dephosphorylation.  Plots show two individual repeats each for 
CheY-P measurement with hydroxylamine or imidazole.  (B) Phosphorimaging scan showing the 
loss of 32P from denatured [32P]CheY-P.  CheY was phosphorylated using [32P]CheA-P.  After a 
10 second incubation, SDS was added to denature the proteins.  The reaction was separated into 
three aliquots to which buffer with no nucleophile (lane 1), 250 mM imidazole (lane 2), or 250 
mM hydroxylamine (lane 3) were added.  After incubating for one hour at room temperature, 
reaction components were separated by SDS-PAGE, and loss of radiolabel from CheY was 
detected using a phosphorimager.   
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Figure 3.4  Sensitivity of PhoB-P and CheA-P to imidazole.  (A) Phosphorimaging scans 
showing the loss of 32P from [32P]PhoB-P in the absence (top panel) or presence (bottom panel) 
of 500 mM imidazole at pH 7.5.  Wild type PhoBN was used for this analysis.   (B) 
Phosphorimaging scan showing [32P]CheA-P after a 1-hour incubation with different 
concentrations of imidazole at pH 7.5.  
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Figure 3.5  [32P]CheYMPI-P reaction with imidazole.  Phosphorimaging scans showing changes 
in [32P]CheYMPI-P (SDS-PAGE), [32P]MPI (TLC), and [32P]Pi (TLC) over time upon reaction of 
CheYMPI-P with 50 mM imidazole at pH 7.5.  The “0” time point was quenched less than 15 
seconds after addition of imidazole to [32P]CheYMPI-P.   
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Figure 3.6  The role of imidazole in an artificial phosphorelay.  (A) Phosphorimaging scan of 
SDS-PAGE gel showing the presence of 32P on protein components in an artificial phosphorelay 
at pH 7.5.  The PhoBN F20D variant was used for this analysis.  (B) Phosphorimaging scan 
showing transfer of [32P] from PhoR to CheYMPI at pH 7.5.  Reaction components in (A) and (B) 
were incubated for 30 minutes at room temperature. 
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Figure 3.7  Structure showing imidazole poised for nucleophilic attack in CheYMPI"BeF3-.  (A)  
Two imidazoles (purple) were complexed with CheY (PDB 5D2C).  One imidazole is oriented 
over the BeF3- (phosphomimic) in a fashion consistent with nucleophilic attack. Another 
imidazole was associated with the metal (light teal).  (B) Electron density map (2Fo-Fc) shows 
the presence of the imidazole over the Be.  In both panels, the divalent metal is light teal, BeF3- is 
green and cyan, and the imidazoles are purple. 
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Figure 3.8  Structures showing imidazole oriented in the active site similarly to Hpt His.  (A) 
The co-crystal structures of CheYMPI"BeF3-"imidazole (PDB 5D2C), Spo0F"BeF3-"Spo0B (PDB 
2FTK)(102), SLN1"BeF3-"YPD1 (PDB 2R25)(101) showing interactions between D+2, T+1, 
and/or T+2 side chains from each RR and the imidazole rings.  CheYMPI/imidazole residues are 
represented by purple, Spo0F/Spo0B by cyan, SLN1/YPD1 by slate, and the phosphomimic 
BeF3- is green and cyan in all three.  Purple dots (CheY D+2, T+1 and T+2), slate dots (SLN1 
D+2, T+1 and T+2) and cyan spheres (Spo0F D+2 and T+1) are non-conserved active site 
residues.  (B) Using the same coloring as panel (A) the imidazole rings from all three structures 
are oriented over the Be within appropriate distance for nucleophilic attack. 
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CHAPTER 4: FUTURE DIRECTIONS AND CONCLUSIONS 
4.1 PROBING FUNCTIONAL VARIATION WITHIN PROTEIN FAMILIES 
4.1.1 Broad application of bioinformatics-guided assessment of functional variation 
within protein families.  One prevailing purpose within the field of data science is to glean as 
much knowledge as possible from large volumes of data.  As it applies to genomics, the use of 
bioinformatics to determine the proteins encoded within a genome and assign broad function to 
those proteins has been hugely beneficial – for example, in the case of determining factors of 
acquired drug resistance in pathogens (111-113).  
As it pertains to biochemical and biophysical analyses of functional variation amongst 
proteins of a particular family, there is more to extract from protein sequence information.  
Typically, members of a protein family are assigned by identifying conserved domains.  
Functionality within a protein family is typically assessed by changing conserved residues on a 
representative protein to alanines and assaying the mutant protein.  While such an approach is 
informative in determining properties that can be applied to the protein family as a whole, the 
approach does not account for functional variation within a protein family.  In the case of TCS 
conserved domains, variation in detectable stimuli and biological responses is in part achieved by 
variation in non-conserved input and output domains (32, 50).  However, functional variation 
within the conserved domains of TCSs – particularly receiver domains, as the response-
mediating component – is indicative of the fact that molecular strategies must be tuned to the 
timescales of the biological processes being regulated (23, 36, 51, 52).  TCSs regulate biological 
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processes on timescales that range from slow (such as cell development) to fast (such as 
chemotaxis) such that reported rate constants for RR autodephosphorylation – indicative of the 
baseline signaling timescale - span six orders of magnitude (51, 52).   
The approach described in Chapter 2 has broad applications to the study of protein 
families.  Essentially, a database of a family of proteins, determined by identification of a 
conserved domain, was analyzed for variations at non-conserved residues of the proteins.  A 
broadly applicable strategy would entail various methods of identification of functionally 
relevant residues to assess (e.g. Ala scanning, molecular modeling, etc.).  Alternatively, non-
conserved residues of interest may also be revealed through co-variation analysis or analysis of 
enrichment associated with variable domains – such as was observed with bioinformatics 
analysis of RR subfamilies.  Similar to our applications to the study of receiver domains, 
structural analysis can be used to identify residues that are appropriately positioned to influence 
protein function.   
As reported in Chapter 2, alignments of receiver domain sequences revealed a striking 
distribution of amino acids at two non-conserved positions of interest; 5% of possible amino acid 
pairs at the two positions represented 50% of protein sequences in the database.  Bioinformatics 
elucidated a data set that was both reflective of nature and experimentally feasible. We are aware 
of only two cases in which similar approaches have been applied to assess functional variation 
within protein families.  Assessment of functional variation within aminopeptidases, a family of 
ubiquitous enzymes across all kingdoms of life, involved making substitutions to only one 
position (114).  In nucleotide binding domains of CFTRs, residues at two amino acid positions 
were found to have co-evolved.  Functional variation was assessed by making single and double 
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substitutions at both positions reflecting only one amino acid pairing (115).  Our work may 
represent the only reported case of extensive analysis applying a similar strategy. 
4.1.2 Expanded assessment of non-conserved active site residues in receiver domains.  
As stated previously, residues at D+2/T+2 account for a small fraction of the total range in wild 
type RR autodephosphorylation rate constants; other features within receiver domains must also 
contribute.  Two other positions located in the active site have been assessed for the ability to 
modulate autodephosphorylation.  A handful of substitutions at D+1 and T+1 (one positions C-
terminal to the site of phosphorylation and conserved threonine, respectively) showed that 
residues at each position could, individually, modulate autodephosphorylation over a ~10-fold 
range (D+1 analyzed by Stephani Page, T+1 by Robert Immormino).  There is a possibility that 
changing D+1, D+2, T+1, and T+2 simultaneously could account for a significant portion of the 
total range in reported wild type RR autodephosphorylation rate constants.  However, there are 
160,000 possible quadruplet combinations.  Using bioinformatics, we can identify quadruplets 
based on what is found in nature, and identify an experimentally feasible approach for analysis.  
In the non-redundant database of receiver domain sequences, 78% of sequences contain Ile, Leu, 
or Val at D+1, and 85% of sequences contain Ala, Gly, or Ser at T+1.  It is reasonable to propose 
that analysis of D+1, D+2, T+1, and T+2 quadruplets would include an experimentally feasible 
number of variants.  In fact, ~150 combinations represent 50% of the quadruplet sequences 
found in naturally occurring receiver domains. 
4.1.3 Potential avenues for additional analysis of functional variation of receiver 
domains based on response regulator sub-categories.  Analysis of receiver domain sub-
families also represents a beneficial tool.  Broadly, the ability to separate protein sequences from 
a larger database into sub-databases based on other domains that are present allows for 
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assessment of enrichment within non-conserved features. For future probing of receiver domains, 
there are two potentially informative avenues.  First, the enrichment of D+2 and T+2 pairs in a 
subfamily accounted for large percentages of the pairs prevalent in the whole database.  For 
example, 78% of receiver domains containing NE at D+2/T+2 were accounted for in the single 
domain response regulator family.  What could also be informative are the D+2/T+2 pairs that 
were rare in the large database, but that were enriched within a particular subfamily.  For 
example, receiver domains with KS at D+2/T+2 represent only 0.6% of sequences overall; 
however, KS is one of the top ten pairs that make up single domain response regulators.  Further, 
90% of receiver domains containing the KS pair are found in single domain response regulators.  
In general, analysis of protein subfamilies entails identifying other domains that are present with 
conserved domains, then grouping individual conserved domain sequences based on associations 
with, for example, variable output or input domains.  
There is interest in deeper probing of phosphorelays for determinants of phosphotransfer 
reactions, particularly, between receiver domains and Hpts (45).  Results reported in Chapter 2 
suggest that non-conserved active site residues may discriminate between nucleophiles – water 
or Hpt histidines - and that discrimination may be enhanced in phosphorelay-associated receiver 
domains.  We can potentially group receiver domain sequences based on association with 
phosphorelays.  If we can distinguish between the ‘D1’ and ‘D2’ receiver domains, analysis 
could potentially reveal determinants of phophorelay phosphotransfer reactions that are 
distinguishable from canonical TCSs.   
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4.2 APPLICATIONS OF IMIDAZOLE IN TWO-COMPONENT SYSTEMS 
4.2.1 Applications of imidazole in analysis of phosphotransfer reactions.  Over the 
past two decades, small molecule phosphodonors (34, 64) have been an important tool in the 
advancement of knowledge of TCSs; from dissecting contributions of sensor kinases and 
response regulators in His ! Asp phosphotransfer (34, 82, 116) to analysis of coupling between 
phosphorylation kinetics of receiver domains, receiver domain multimerization and/or output 
domains (63, 84, 117, 118).  Similarly, our discovery of imidazole as a small molecule 
phosphoacceptor has the potential to enhance exploration of determinants of Asp ! His 
phosphotransfer.  One approach takes advantage of being able to separate the functional group of 
a histidine, imidazole, from the rest of an Hpt domain.  Chemical rescue using imidazole has 
been used to elucidate contributions of enzyme components to the catalysis of a reaction (119, 
120).  Chemical rescue entails removal of a catalytic residue in an enzyme – such as a His – by 
substitution to an alanine or glycine.  A small molecule with similar properties as the removed 
residue – such as imidazole - is then added during assaying to supplement the loss of the 
catalytic residue.  This strategy can be used to probe for contributions to catalysis within the 
enzyme.   
A similar approach may be useful for analysis of phosphorelay components.  Results 
reported in Chapter 3 suggest that the Hpt must contribute to Asp ! His phosphotransfer 
reactions.  While rate constants for Asp ! His phosphotransfer from wild type phosphorelay 
receiver domains to Hpts are as fast as 105 M-1s-1, phosphotransfer reactions from receiver 
domains to imidazole were slower than 10 M-1s-1.  Potential contributions from the Hpt include 
positioning of the histidine residue, exclusion of water from the active site, and/or binding.  One 
avenue to probe for contributions from the Hpt is to react RR-P with imidazole in the presence 
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and absence of an Hpt domain with the His removed.  In theory, if the rate constants for 
phosphotransfer to imidazole are enhanced in the presence of the Hpt domain, we could 
potentially quantify the contributions of each component.  Conversely, the result with imidazole 
inspires the use of a small molecule phosphodonor, acetyl phosphate, to replace the 
phosphorylated Asp.  Reacting an Hpt domain with acetyl phosphate in the presence and absence 
of a receiver domain may also indicate contributions from the different protein components.  
Preliminary data suggests that, on its own, a phosphorylated Hpt does not react with acetyl 
phosphate (unpublished, Ruth Silversmith).  This result is consistent with receiver domains 
containing the core catalytic machinery of phosphotransfer reactions.  However, perhaps 
phosphotransfer from acetyl phosphate to an Hpt may be observed in chemical rescue analysis in 
which a receiver domain lacking the Asp (site of phosphorylation) was included. 
4.2.2 Comparisons between effects with water and imidazole may reveal mechanistic 
insight into receiver domain dephosphorylation reactions. The x-ray crystal structure of 
activated CheYMPI in complex with imidazole indicates that some mechanistic insight into the 
influence of non-conserved active site residues may be gained in comparing rates constants for 
water- versus imidazole-mediated dephosphorylation.  Results in Chapter 2 indicated negative 
charge as a key feature of influence by residues at D+2 and T+2.  One hypothesis is that residues 
at D+2 and T+2 directly interact with the nucleophile (water) in the transition state.  The 
CheYMPI"Mn2+"BeF3-"imidazole structure showed residues at D+2, T+1, and T+2 directly 
contacting the nucleophile (imidazole).  Interestingly, CheYwt (NE at D+2/T+2) had the lowest 
relative sensitivity to imidazole of all CheY variants that were assessed; the reaction with 
imidazole was not as fast as other CheY variants relative to the reaction with water.  One 
explanation for the diminished relative sensitivity of CheYwt is that the negatively charged 
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residue is detrimental for the reaction with imidazole in contrast to enhancing the reaction with 
water.  Preliminary data showed that methylated imidazole derivatives (in which the site of 
methylation varied) influence the dephosphorylation reaction differently (unpublished, Frederick 
Ferguson and Ruth Silversmith).  We can potentially use imidazole derivatives with varying 
characteristics to further probe for mechanistic insight into receiver domain dephosphorylation. 
CONCLUSIONS 
Receiver domains contain the core catalytic machinery of phosphotransfer in TCSs.  
Other than ATP ! His phosphotransfer catalyzed by SKs, receiver domains catalyze His ! Asp, 
Asp ! water, and Asp ! His.  In addition to reactions of canonical TCSs and phosphorelays, 
receiver domains catalyze their own phosphorylation with acetyl phosphate, which is a 
physiologically available small molecule (121-124).  When considering the fine-tuning to 
coordinate timescales of phosphotransfer to timescales of detection and response, the flow of 
phosphoryl groups around the receiver domain must be appropriately regulated.  Probing 
receiver domains for determinants of phosphotransfer reactions is important, not only for basic 
knowledge of TCSs, but in understanding a fundamental strategy employed by all domains of 
life to encode the presence of stimuli.  This work presents novel approaches to answering 
fundamental questions regarding phosphotransfer reactions in TCSs and functional variation 
within protein families.  
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